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ABSTRACT 
The skin is the largest organ in the human body and is prone to injury (Martin & Nunan, 
2015). Wounds usually heal in a timely, well-regulated fashion by following a predictable 
sequence of events (Tsourdi et al., 2013). Chronic wounds, however, take longer than 
three months to heal, and display unique characteristics such as disrupted patterns of 
cytokine expression and a prolonged inflammatory phase which is detrimental (Martin & 
Nunan, 2015; Wetzler et al., 2000). Interleukin 6 (IL-6) and tumour necrosis factor alpha 
(TNF-α) are both cytokines which indicate inflammation (Barrientos et al., 2008). Diabetes 
mellitus (DM) is an endocrine disorder that is reaching epidemic proportion and whose 
prevalence is increasing worldwide (Cho et al., 2018). In DM, chronic wounds called 
diabetic foot ulcers (DFUs) are a serious complication which often leads to lower limb 
amputations (Sohn et al., 2010). The treatment of DFUs is notoriously difficult and new 
therapies are urgently needed to decrease the burden on national health care systems 
(Cho et al., 2018).  
 
Homeopathy is a complementary health system which is effective in treating a variety of 
disease conditions (Fisher, 2012). The substances Calendula officinalis (C. officinalis), 
Hypericum perforatum (H. perforatum) and Echinacea purpurea (E. purpurea) effectively 
stimulates wound healing in herbal form (Parente et al., 2012; Samadi et al., 2010; Rezaie 
et al., 2013). These remedies are also indicated in the homeopathic literature for the 
treatment of wounds, however there are limited studies on their effectiveness (Hering, 
1997; Boericke, 1999; Sinha, 1981). 
 
Photobiomodulation (PBM) is a therapeutic intervention which involves using low-
intensity laser light at specific wavelengths to treat a variety of medical conditions 
(Andrade et al., 2014). PBM is effective in accelerating wound healing in a variety of 
experimental models, including DFU in DM (Carvalho et al., 2016; Kaviani et al., 2011).  
 
The aim of this study was to determine the effects of a 3 cH homeopathic solution 
containing C. officinalis, H. perforatum and E. purpurea and PBM, both as single therapies 
and in combination in an in vitro diabetic wounded cell model. 
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Commercially available human skin fibroblasts (WS1) were used as an in vitro model in 
this study. Normal cell models were grown in supplemented culture medium and diabetic 
cell models were grown in the same with additional glucose to generate a final glucose 
concentration of 22.6 mMol/L. Cells were sub-cultured at confluency in 3.4 cm diameter 
culture dishes and subjected to the ‘scratch assay’ (Felice et al., 2015) using a sterile 
pipette tip to simulate a wound. For the PBM models, cells were irradiated using laser 
light with a wavelength of 660 nm and a dose of 5 J/cm2. This dose and wavelength is 
well established within the research centre, and has been shown to stimulate healing in 
this in vitro diabetic wounded model (Houreld et al., 2018; Ayuk et al., 2016; Jere et al., 
2018). For homeopathically treated models a homeopathic solution containing 3 cH C. 
officinalis, H. perforatum and E. purpurea prepared in 5% ethanol was added to culture 
medium and incubated for 48 h. In cells treated with both these therapies, the 
homeopathic solution was added first and then plates were irradiated. Controls were non-
wounded cells, and wounded cells that received neither of the treatments, as well as an 
alcohol control group where 5% ethanol was added to culture medium. Images were 
captured using a microscope (Olympus CKX41) coupled to a digital camera at 0 h, 24 h 
and 48 h after treatment to visualise cellular morphology. For biochemical assays, culture 
medium was collected 48 h post-treatment and cells were detached from culture plates. 
A proportion of the culture medium was frozen to perform the enzyme-linked 
immunosorbent assay (ELISA), and a proportion was used immediately to perform the 
lactate dehydrogenase (LDH) membrane integrity assay to determine cytotoxicity. 
Detached cells were used to perform the adenosine triphosphate (ATP) luminescence 
assay and the Trypan Blue exclusion assay, measures of cellular viability. ELISA was 
performed using commercially available kits to determine the concentration of pro-
inflammatory cytokines IL-6 and TNF-α in culture medium.  
 
Morphological changes revealed that both PBM and the homeopathic solution stimulated 
wound healing in diabetic wounded cells, and that combining these therapies had an even 
greater effect. Cellular viability was not affected by either homeopathic solution or PBM 
but combining them caused increased viability as indicated by ATP results. Trypan Blue 
results revealed decreased viability, contradicting the ATP results. Cytotoxicity was 
decreased by the homeopathic solution complex and in the combination therapy group. 
TNF-α concentration remained unchanged with both PBM and homeopathic solution as 
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single treatment interventions but combining them increased TNF-α concentration. PBM 
decreased IL-6 concentration, indicating an anti-inflammatory effect.  
 
These cellular changes indicate that combining PBM and a 3 cH solution containing C. 
officinalis, H. perforatum and E. purpurea holds potential for accelerating wound healing 
in the context of DFUs. Further research is necessary to establish effects in more complex 
models.  
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CHAPTER 1 
INTRODUCTION 
1.1 Foreword 
The skin is the largest organ in the human body and forms a barrier between the external 
and internal environment (Moore, Dalley & Agur, 2010:12). It fulfils many essential 
functions such as protecting us from harmful microbes and other detrimental 
environmental conditions (Moore et al., 2010:12). Wounds, or a disruption in normal skin 
structure and function, commonly occur and activates the process of wound healing, 
leading to sustained renewal of skin by restoration of anatomy and function (Martin & 
Nunan, 2015). Wound healing involves a multitude of cell types and chemical messengers 
such as cytokines, which activates a variety of tightly controlled cellular processes 
(Tsourdi et al., 2013; Diegelmann & Evans, 2004). In chronic wounds the healing process 
is disrupted and prolonged and characterised by an extended inflammatory phase (Martin 
& Nunan, 2015). People living with diabetes mellitus (DM) face a host of health 
complications such as slow-to-heal chronic diabetic foot ulcers (DFUs), which can 
frequently result in lower extremity amputations (Sohn et al., 2010). These wounds are 
notoriously difficult to treat and living with them negatively affects patients’ quality of life 
(Barg et al., 2017; Game et al., 2016).  
 
Skin fibroblasts are diverse cells that occur in the dermis (Tracy et al., 2016). They play 
an essential role in wound healing, including breaking down the fibrin clot and generating 
new extracellular matrix (ECM) (Bainbridge, 2013). They also respond to a variety of 
cytokines and produce a multitude of them (Barrientos et al., 2008). In addition, they are 
a popular cell model used for in vitro studies, especially in the field of wound healing 
(Felice et al., 2015).   
  
Herbal preparation originating from as Calendula officinalis L. (C. officinalis), Hypericum 
perforatum L. (H. perforatum) and Echinacaea purpurea (L.) Moench (E. purpurea) have 
shown wound healing effects (Maver et al., 2015; Barnes et al., 2001; Rezaie et al., 2013). 
When prepared in homeopathic form (C. officinalis, H. perforatum and E. purpurea 
respectively) these effects have also been demonstrated, but to a lesser extent (Bresler 
et al., 2007; Raak et al., 2012; Pedalino et al., 2004). These plants induce wound healing 
by a variety of mechanisms, such as decreasing inflammation and oedema in the case of 
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C. officinalis (Muley et al., 2009), increasing re-epithelialisation and granulation tissue 
with H. perforatum (Süntar et al., 2010; Han et al., 2017) and modifying cytokine 
expression and leucocyte activity in the case of E. purpurea (Manayi et al., 2015; Oláh et 
al., 2017).  
 
PBM can also be used to stimulate wound healing. This therapy involves using low-
powered light at specific wavelengths to modify a variety of physiological processes which 
results in faster healing (Avci et al., 2013). It has been shown to be effective for wound 
healing in laboratory and clinical trial settings. PBM decreases pain and the wound area 
and results in faster wound healing (Carvalho et al., 2016; Kaviani et al., 2011). These 
affects could be ascribed to increased collagen production and angiogenesis, positive 
effects on mitochondrial dynamics and altered gene expression of adhesion molecules 
(Tatmatsu-Rocha et al., 2018; Houreld et al., 2018).  
 
1.2 Problem Statement 
DM is one of the great non-communicable diseases of our time and it was estimated that 
globally 451 million people between 18 and 99 years old were diabetic in 2017 (Cho et 
al., 2018). DM constitutes a group of metabolic diseases involving persistently elevated 
glucose levels resulting from defective insulin secretion or action, or a combination of 
these. Chronic DFUs are a frequent complication of DM, occurring due to a variety of 
factors present in the disease. Extrinsic factors include trauma or repeated mechanical 
stress to the feet that have decreased sensitivity due to neuropathy or ischaemia as a 
result of vascular disease (Tsourdi et al., 2013). A thickened basement membrane is 
central to diabetic vascular disease leading to non-healing ulcers. Intrinsic factors are the 
direct result of hyperglycaemia on the process of wound healing and could implicate 
mechanisms such as advanced glycation end-products (AGEs), which lead to the 
production of inflammatory cytokines as well as abnormal proliferation of keratinocytes. 
Hyperglycaemia-related effects also lead to decreased fibroblast migration and 
proliferation (Emanuelli et al., 2016). In addition, decreased immune function in DM could 
contribute to poor wound healing, possibly due to the abnormal cytokine responses 
present in DM (Tsourdi et al., 2013). 
 
It has been demonstrated that PBM is effective in stimulating wound healing, and also in 
the context of DFUs (Carvalho et al., 2016; Kaviani et al., 2011). As a therapy, it has many 
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advantages such as being safe and convenient, especially with the increasing availability 
of home-use light emitting diode (LED) devices (Avci et al., 2013). The mechanisms 
driving the healing effects are not fully understood; however, several theories exist 
including actions on cytochrome c oxidase (COX) and light-sensitive ion channels (De 
Freitas & Hamblin, 2016).  
 
Basic research on the molecular effects of homeopathic remedies is in its infancy, yet 
studies reveal that C. officinalis, H. perforatum and E. purpurea can modulate wound 
healing in homeopathic form. In addition, all three of these plants, when prepared 
homeopathically,are indicated for wound healing in the traditional homeopathic literature 
(Hering, 1997; Boericke, 1999).  
 
The unique combination of these homeopathic remedies with PBM has not been 
investigated.  
 
1.3  Aim of the Study 
This study aims to investigate the effects of a 3 cH homeopathic solution containing C. 
officinalis, H. perforatum and E. purpurea combined with PBM therapy in an in vitro 
diabetic wounded cell model. 
 
1.4  Objectives 
The main objectives of this study were to investigate the effect of a homeopathic solution 
containing C. officinalis, H. perforatum and E. purpurea and PBM using 5 J/cm2 at 660 
nm on: 
• the migration and proliferation of normal, wounded, and diabetic wounded 
fibroblasts, 
• the cell viability indicated by the amount of adenosine triphosphate (ATP) 
released in these models, and by performing the trypan blue assay, 
• the cytotoxicity indicated by the amount of lactose dehydrogenase (LDH) 
released in these models, and 
• the expression of the pro-inflammatory cytokines interleukin-6 (IL-6) and 
tumour necrosis factor alpha (TNF-α) in these models. 
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1.5 Hypothesis 
Treatment with the homeopathic solution and PBM both singly and combined leads to 
more effective wound healing compared to controls in diabetic and normal cell models. 
 
1.6 Null Hypothesis 
Treatment with the homeopathic solution and PBM both singly and combined does not 
lead to more effective wound healing compared to controls in diabetic and normal cell 
models. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1  The Skin  
2.1.1 Structure and function 
The skin forms the integumentary, or covering, system of the body and comprises our 
largest organ (Moore et al., 2010:12). Skin is composed of three main layers: the 
epidermis, dermis and subcutis or hypodermis (Figure 2.1) (Young, Lowe, Stevens & 
Heath, 2006:167). Each layer has a unique structure and is composed of a distinct 
collection of cells and tissues. Nevertheless, there is a degree of inter-subject variability 
in the composition of human skin (Groenendaal et al., 2010). The epidermis is the 
outermost layer. It is highly specialised and self-regenerating, and produces the 
protective, somewhat waterproof protein keratin. It also contains melanocytes which 
produce pigment for sun protection, Langerhans cells which can recognise foreign 
antigens, and Merkel cells with touch receptors (Young et al., 2006:168). A specialised 
basement membrane tightly binds the epidermis to the underlying dermis. Rete ridges – 
epidermal downgrowths – penetrate the dermis and provide even stronger tethering 
(Young et al., 2006:168).  
 
The dermis consists of a harder layer with horizontally arranged collagen and elastic 
fibers with fibroblasts. The dermis, situated beneath the epidermis, is less dense and 
contains many small blood vessels as well as sensory nerve endings and sense organs 
in certain areas (Young et al., 2006:168). The subcutis is a layer of adipose tissue which 
is frequently compartmentalised by downward extensions of collagen from the dermis. 
The function of the subcutis is shock absorption, thermal insulation and fat storage. The 
dermis and subcutis contain a variety of skin appendages – hair follicles, sebaceous 
glands, eccrine glands and ducts, as well as apocrine glands in some areas (Young et 
al., 2006:168).  
 
Skin fulfils various crucial functions including containing the body structures and fluids; 
protecting the organism from potentially harmful environmental conditions such as fluid 
loss, ultraviolet radiation and microbes; regulating heat by sweating and controlling blood 
vessel diameter; creating sensations such as pain; and synthesising vitamin D (Moore et 
al., 2010:12).  
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2.2 Wound Healing  
A wound involves damage to the skin and can occur from various processes (Martin & 
Nunan, 2015). Wounds can be further classified as acute or chronic (Figure 2.2). Acute 
wounds heal in a highly coordinated fashion which leads to restored skin with its functional 
components (Martin & Nunan, 2015). Chronic wounds are classified as barrier defects 
that do not heal within three months and involve a disruption of the typical wound healing 
process. Chronic wounds (DFUs, venous leg ulcers or pressure ulcers) may often 
become infected and display an abnormal inflammatory profile (Martin & Nunan, 2015).  
 
Damage to the skin results in activation of wound healing (Martin & Nunan, 2015). 
Standard wound healing is a complex and dynamic physiological process involving a 
series of orchestrated events; these comprise the phases of haemostasis, inflammation, 
proliferation and remodelling, all tightly controlled by various growth factors and cytokines 
(Diegelmann & Evans, 2004).  
 
Figure 2.1: Layers of the skin (Hansen, 2017:4). 
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2.2.1  Phases of wound healing 
The healing process starts at the moment of injury and the first phase, haemostasis, 
occurs within an hour of injury (Tsourdi et al., 2013). Vasoconstriction and clotting are the 
hallmarks of this phase and both are initiated by platelets. Blood platelets encounter 
exposed elements of the ECM, such as collagen, which then triggers the release of 
essential growth factors and cytokines, such as platelet-derived growth factor (PDGF) 
and transforming growth factor beta (TGF-β) (Diegelmann & Evans, 2004). These events 
activate the clotting cascade and initiates the next phase, namely inflammation (Tsourdi 
et al., 2013).   
 
Neutrophils and macrophages play an important role in the inflammatory phase, and this 
phase lasts up to seven days. Initially, neutrophils enter the wound site and phagocytose 
debris such as bacteria, foreign materials and damaged tissue (Diegelmann & Evans, 
2004). Next, monocytes are attracted to the site where they differentiate into 
macrophages. They are responsible not only for continued phagocytosis but for releasing 
a host of growth factors which promote angiogenesis and fibroplasia, which are important 
initial steps for ECM formation (Tsourdi et al., 2013).  
 
Figure 2.2: The cellular and molecular differences between acute healing wounds and 
chronic non-healing wounds (Nunan et al., 2014). 
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The proliferation phase begins two days after injury and can last up to 20 days. Tissue 
granulation and angiogenesis characterise this phase. Growth factors such as PDGF, 
macrophage angiogenesis factor and angiotensin are involved with angiogenesis. At the 
same time, granulation tissue is epithelialised so that it is covered with a barrier of cells 
(Tsourdi et al., 2013). The final phase of wound healing involves widespread remodelling 
of tissue. This phase lasts longer – from one week to six months post-injury. Proteoglycan 
and collagen molecules replace the temporary wound matrix and become organised into 
thicker bundles. In this way scar tissue, stronger but more rigid than skin, is formed 
(Tsourdi et al., 2013).  
 
2.2.2  Cytokines and growth factors involved in wound healing 
It is evident that the role of cytokines and growth factors are central to the physiology of 
wound healing. Successful wound healing depends on the complex integration of these 
signalling molecules to coordinate cellular functions (Barrientos et al., 2008). Growth 
factors and cytokines are biologically active polypeptides that can change the growth, 
differentiation and metabolism of their target cells. Binding to specific cell surface 
receptors or ECM proteins puts a cascade of molecular events into motion, resulting in 
the transcription of proteins that control various cellular functions (Barrientos et al., 2008). 
The major growth factors involved are the epidermal growth factor (EGF) family, fibroblast 
growth factor (FGF) family, TGF-β family, PDGF and vascular endothelial growth factor 
(VEGF).  
 
Some important cytokines involved are interleukin-1 (IL-1), IL-6 and TNF-α. These three 
cytokines are pro-inflammatory and are increased during the inflammatory phase of 
wound healing (Barrientos et al., 2008). They also all play a role in re-epithelialisation. IL-
1 is manufactured by neutrophils, macrophages, monocytes and keratinocytes. It acts on 
keratinocytes to increase migration and proliferation, as well as activating fibroblasts and 
increasing FGF-7 release. IL-6 is produced by neutrophils and monocytes and is 
important for initiation of wound healing (Barrientos et al., 2008). Fibroblasts also release 
IL-6 and other pro-inflammatory cytokines upon activation of the nuclear factor kappa B 
(NF-κB) family of receptors (Sundararaj et al., 2009; Flavell et al., 2008). Hernández-
Caldera et al. (2018) demonstrated that human periodontal ligament fibroblasts respond 
to IL-6 by increasing synthesis of C-reactive protein as well as Th-1 and Th-17-related 
cytokines – all markers of inflammation.  IL-6 stimulates keratinocyte proliferation and 
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mitosis and attracts neutrophils (Barrientos et al., 2008).  Its expression is increased 15 
to 20 min after injury, with marked expression occurring 60 to 90 min after injury (Grellner, 
2002). The importance of IL-6 in wound healing is demonstrated in IL-6 deficient mice. 
They exhibit delayed wound healing with decreased expression of IL-1, chemokines, 
adhesion molecules, TGF-β1 and VEGF (Lin et al., 2003).  
 
TNF-α can either stimulate or inhibit healing, based on its concentration and on the length 
of time cells are exposed to it (Barrientos et al., 2008). TNF-α expression follows the 
same timing pattern as IL-6, with peak levels occurring 60 to 90 min after injury (Grellner, 
2002). Low levels of TNF-α encourages healing as it stimulates inflammation and the 
production of macrophage produced growth factors. At higher levels, and especially over 
prolonged periods, the situation is reversed and TNF-α impedes healing; it suppresses 
production of ECM proteins and tissue inhibitor of metalloproteinases (TIMPs) while 
increasing matrix metalloproteinases (MMPs). This situation leads to breakdown of the 
ECM and collagen, and inhibition of growth factors and target cell receptors, culminating 
in inhibition of healing. Elevated levels of TNF-α are present in chronic wounds 
(Barrientos et al., 2008).  
 
2.2.3  Fibroblasts and wound healing 
Fibroblasts are essential for wound healing, because they fulfil important roles such as 
breaking down the fibrin clot and generating new ECM and other collagen-rich structures 
(Bainbridge, 2013). Fibroblasts are the most abundant cell type in the human dermis, yet 
they are relatively poorly defined. These diverse cells have the remarkable capability to 
change their function or even transform into new cell types, based on where in the body 
they are located (Tracy et al., 2016). The most common example of this is their ability to 
transform into myofibroblasts which can contract and is implemented in the process of 
wound contraction (Tracy et al., 2016).  
 
It is still unclear exactly how fibroblasts adapt their structure and function; however, it is 
thought that both soluble signalling molecules and the cells’ extracellular environment 
play a role (Tracy et al., 2016).  FGF-2, or basic FGF, promotes fibroblast migration and 
stimulates their production of collagenase. TGF-β2, TGF-β3 and PDGF also attract 
fibroblasts to the wound site (Tracy et al., 2016). PDGF can increase fibroblast 
proliferation and thus ECM production, and is responsible for inducing the myofibroblast 
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phenotype which stimulates contraction of collagen matrices (Barrientos et al., 2008). 
Fibroblasts make at least 17 different growth factors, such as EGF, FGF-2, TGF-β, PDGF 
and VEGF, which reflects their central role in wound healing (Barrientos et al., 2008).   
 
2.3  Diabetes Mellitus  
2.3.1.  Pathogenesis and epidemiology 
DM is one of the great non-communicable diseases of our time and rates have been 
increasing dramatically over recent decades. It was estimated that globally 451 million 
people between 18 and 99 years old were diabetic in 2017 (Cho et al., 2018). It is 
estimated that this figure will rise to 693 million by 2045. Three quarters of people 
suffering from DM live in low- and middle-income countries. DM significantly increases 
premature mortality risk and statistics reveal it resulted in 6.8% of global deaths in 2010 
(Roglic and Unwin, 2010). 
 
DM constitutes a group of metabolic diseases involving persistently elevated glucose 
levels resulting from defective insulin secretion, action or a combination of these. It is 
divided into Type 1 and Type 2 DM, which differ in their pathology and usually in their 
clinical presentation (Ozougwu et al., 2013). Type 1 is characterised by a lack of insulin 
secretion by pancreatic beta cells, while Type 2 is due to decreased sensitivity of target 
tissues to insulin – a condition called insulin resistance. Type 1 DM occurs due to an 
autoimmune reaction which destroys the pancreatic beta cells which are responsible for 
producing insulin. This condition is most commonly diagnosed in children around four or 
five years of age, although all age groups can be affected. There is a greater risk for 
family members of Type 1 DM patients to be diagnosed with it, and to suffer from other 
autoimmune conditions. The pathophysiology includes deficient insulin production as well 
as excessive glucagon production, leading to a condition called diabetic ketoacidosis if 
the patient is not administered  insulin. Other derangements include negative energy 
balance leading to weight loss and increased food intake, increased blood triglycerides 
and catabolism of proteins (Ozougwu et al., 2013).  
 
Type 2 DM occurs much more frequently and accounts for 90% of cases of DM. It is 
usually diagnosed later in life than Type 1 DM. The prevalence of Type 2 DM has 
increased significantly in recent years, with poor diet and low physical activity considered 
to be risk factors for its development (Ozougwu et al., 2013). The genetic basis for 
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developing Type 2 DM has long been recognised, and epigenetic changes play a role in 
its pathogenesis, providing the link between genetic and environmental factors in this 
disease. Patients with Type 2 DM have generalised dysregulated DNA methylation, likely 
with defective protection against oxidative stress and cancer (Karachanak-Yankova et al., 
2016). Some ethnic groups, such as certain populations of Indians, have a greatly 
increased risk of developing Type 2 DM (Ozougwu et al., 2013). Type 2 DM is 
characterised by decreased insulin production and increased insulin resistance. 
Pancreatic beta cell function usually declines gradually. Risk factors that are strong 
predictors of developing Type 2 DM are a family history of the disease, increased body 
mass index, increased liver enzymes, obesity, smoking and reduced insulin secretion and 
action (Lyssenko et al., 2008).  
 
Type 2 DM accounts for well over 90% of DM cases in Sub-Saharan Africa (Hall et al., 
2011). In South Africa the prevalence of type 2 DM is estimated at 9% in people over 30 
years (Bertram et al., 2013). In addition, significant disability is associated with DM such 
as retinopathy, amputations, stroke-related disability and ischaemic heart disease-
associated disability (Bertram et al., 2013).  
 
2.3.2  Chronic wounds in diabetes mellitus 
2.3.2.1 Background 
Chronic wounds are another complication of DM. Wounds commonly occur on the feet of 
diabetic patients, and due to a complicated host of factors, they heal poorly and can lead 
to development of DFUs. DFUs are common, and it is estimated that the lifetime risk of 
developing a DFU is 25% among the diabetic population (Singh et al., 2005). This is a 
serious complication because a DFU increases the risk for lower extremity amputation 
(Sohn et al., 2010) which in turn increases mortality rates in diabetic patients (Hoffstad et 
al., 2015). 
 
In a systemic review, Rigato et al. (2018) found a pooled prevalence of 4.6% for DFUs 
among diabetic patients in Sub-Saharan countries. DFUs are difficult to treat, and they 
have a recurrence rate of more than 50% after three years (Boulton et al., 2005). This is 
a great problem especially in Sub-Saharan Africa where complications related to the 
diabetic foot are a leading cause of hospital admission, amputation and mortality among 
diabetic patients (Boulton et al., 2005). This may be due to unique complicating factors 
12 
 
prevalent in this region such as unhygienic conditions, poverty, co-existing human 
immunodeficiency virus (HIV) infection, barefoot gait, low income and cultural practices 
(Boulton et al., 2005). These factors have serious implications for the burden on national 
health systems; for instance the annual cost of treating a diabetic foot was 8 659 US 
dollars (USD) per patient in Sweden (Ragnarson Tennvall & Apelqvist, 2004), while the 
estimated global healthcare expenditure on people living with DM was 850 billion USD in 
2017 (Cho et al., 2018).  
 
In addition, DFUs affect quality of life. In a qualitative study of patients’ experiences, it 
was found that DFUs and lower extremity amputations were highly disruptive in terms of 
independence and function (Barg et al., 2017). Patients are often immobilised as part of 
their care and must stop working and suffer a great loss of autonomy during these times 
(Barg et al., 2017).  
 
2.3.2.2 Aetiology of diabetic foot ulcers 
Distal sensory neuropathy, autonomic neuropathy and peripheral vascular disease (PVD) 
occur commonly in diabetics and are the main factors implicated in the development of 
DFUs (Boulton, 2013). There is no single cause of DFUs, and ulceration usually occurs 
after the interaction of risk factors (Boulton, 2013). For example, minor injuries often 
become infected, but the injury remains undetected by the patient due to neuropathy. In 
this scenario an ischaemic ulcer results due to poor blood supply, caused by PVD.  
 
Peripheral neuropathy is a very important player in the aetiology of DFUs. In sensory 
neuropathy small sensory nerve fibers that indicate the sensation of pain and temperature 
are affected (Boulton, 2013). This is a dangerous situation because the foot becomes 
insensitive to pain, a protective mechanism, leading to a higher risk of injury. Wasting of 
small muscles in the foot may occur due to the dysfunction of motor nerves. This could 
lead to foot deformities, resulting from an imbalance between flexor and extensor muscles 
which causes clawing of the toes and prominence of metatarsal heads; this in turn 
increases the risk for ulcer formation (Boulton, 2013).  
 
In addition, nerves of the autonomic nervous system are affected in sympathetic 
autonomic neuropathy. This leads to reduced sweating on the foot, dry skin which may 
13 
 
crack or fissure, and increased blood flow (if the patient does not have PVD) due to 
impaired vasoconstriction (Boulton, 2013).   
 
2.3.2.3 Molecular mechanisms of poor wound healing in diabetic foot ulcers 
Chronic wounds occur due to a combination of factors. These include extrinsic factors 
and intrinsic factors related to the wound and its biology (Tsourdi et al., 2013). Extrinsic 
factors include trauma or repeated mechanical stress to the feet that have decreased 
sensitivity due to neuropathy or ischaemia as a result of vascular disease. Vascular 
disease is a major player in the delayed wound healing of DM. Metabolic abnormalities 
present in DM produces increased reactive oxygen species (ROS) which causes 
inflammation and endothelial dysfunction, in this way triggering vascular disease. In 
addition, the diabetic milieu causes decreased vascular repair mechanisms, altered 
coagulation pathways and epigenetic activation of pro-inflammatory genes among other 
effects, further exacerbating the problem (Paneni et al., 2013).  
 
One microvascular change is related to the basement membrane of capillaries. A 
thickened basement membrane has been found in patients with poor glycaemic control 
(Raskin et al., 1983) which leads to decreased elasticity and capacity for vasodilation. 
This could cause hypoperfusion, which is a mismatch between demand and supply of 
blood and thereby contributes to delayed healing. Another microvascular change is the 
‘capillary steal syndrome’, a situation where blood is shunted away from nutritive 
capillaries to subpapillary capillaries due to autonomic neuropathy (Fagrell et al., 1999; 
Chao & Cheing, 2009).  
 
Intrinsic factors related to poor wound healing in diabetics are the direct result of 
hyperglycaemia itself (Tsourdi et al., 2013). Markuson et al., (2009) demonstrated the 
correlation between hyperglycaemia and delayed healing; they showed that individuals 
with higher haemoglobin A1c (HbA1c) levels, a marker of glucose control, have longer 
healing times of ulcers. The implicated mechanisms likely involve AGEs. These 
molecules have a host of deleterious effects such as producing inflammatory cytokines 
and hindering collagen synthesis (Tsourdi et al., 2013).  
 
Decreased immune function in DM, another intrinsic factor, could contribute to poor 
wound healing, possibly due to an abnormal cytokine response (Tsourdi et al., 2013). 
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Hyperglycaemia increases ROS production which in turn promotes IL-8 release from 
keratinocytes and neutrophil infiltration (Lan et al., 2013). It also inhibits fibroblast 
migration (Xuan et al., 2014). DM is associated with a prolonged inflammatory phase of 
healing. In a study on genetically diabetic mice, Wetzler et al., (2000) demonstrated a 
sustained inflammatory response with prolonged presence of macrophages and 
neutrophils, mediated by the chemokine macrophage inflammatory protein (MIP)-2, and 
macrophage chemoattractant protein (MCP)-1. The pro-inflammatory environment delays 
healing for various reasons such as reducing wound matrix production and triggering 
apoptosis and arrest of granulation tissue cells (Acosta et al., 2008). In addition, impaired 
VEGF responses to hypoxic conditions contribute to deficient neovascularization in 
diabetic tissues (Thangarajah et al., 2009). 
 
Evidence suggests the adverse effects of a hyperglycaemic environment go beyond 
effects on blood vessels and signalling molecules. Cahn et al., (2016) investigated 
differences in vascularisation and erythrocytes in diabetic patients with and without DFUs. 
Not surprisingly, they found worse glycaemic control and earlier date of diagnosis in the 
patients with DFUs. They also demonstrated that erythrocytes in DFU patients had 
decreased deformability, as well as a larger population of minimally deformable 
erythrocytes. This could lead to slower capillary flow and thus decreased nutrient supply 
to injured areas. The mechanism of decreased deformability is suggested to be 
glycosylation of the proteins present in the lipid bilayer walls of erythrocytes leading to 
asymmetry in the wall structure. DM also affects mitochondria, leading to mitochondrial 
dysfunction and disturbed fission-fusion balance (Vincent et al., 2010). Hyperglycaemia 
induces increased fission in neuronal cells, which can have deleterious effects such as 
disturbed energy production and caspase-3 activation (Vincent et al., 2010).  
 
2.3.3  Standard and adjuvant treatment of diabetic foot ulcers 
Usually the patient with a DFU is assessed in terms of their vascular status e.g. using 
pulse assessment, ankle brachial pressure index, Doppler waveform and pulse oximetry, 
and his or her glycaemic control is optimised (Tsourdi et al., 2013). The care of DFUs 
incorporates standard wound care procedures as well as debridement, moisture 
dressings, pressure-offloading and infection management (Baltzis et al., 2014).  
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Debridement refers to the process of removing hyperkeratotic epidermis or callus, 
necrotic tissue, foreign debris and bacteria from the wound bed. This process is 
necessary to remove these elements that inhibit healing. Moisture dressings are applied 
to maintain a moist wound environment but also to protect the wound from the external 
environment, remove wound exudates and encourage regeneration of tissue (Baltzis et 
al., 2014). It remains difficult to develop efficient wound dressings for DFUs. Pressure-
offloading, i.e. redistributing load on the plantar surface of the foot, is a vital component 
in healing DFUs. Surgical interventions such as metatarsal head resection or achilles 
tendon lengthening can also offload pressure; however, these measures may only add 
limited additional value to less radical interventions (Baltzis et al., 2014). In cases of 
significant peripheral arterial disease, revascularisation is indicated because blood flow 
is vital for wound healing and to prevent DFUs and amputation (Baltzis et al., 2014). 
Several revascularising surgical procedures are possible such as angioplasty, 
endarterectomy, and grafting or bypass, and selection will be based on patient 
parameters. The last vital component of DFU care is management of wound infection. 
This involves monitoring the foot for infection, and if present, treating it with oral antibiotics 
in cases of mild or moderate infection. Patients that have systemic inflammatory 
characteristics should be investigated for necrotizing infections, gangrene or deep 
abscesses and may require surgical intervention (Baltzis et al., 2014). 
 
New techniques to treat DFUs are continually being developed. Skin substitutes using 
novel bioprosthetic skin substitutes are an exciting prospect. Usually they consist of a 
biological substance, such as fibroblasts, in combination with a material to cover the 
wound (Han & Ceilley, 2017). While experimental results have been positive and 
encouraging, the costs of this type of treatment remain an obstacle (Han & Ceilley, 2017). 
There are various specialised wound dressings with beneficial effects such as alginate 
which is highly absorbent, or honey-impregnated dressings which are anti-microbial and 
anti-inflammatory (Amin & Doupis, 2016). Several growth factors have been investigated 
due to their ability to stimulate wound healing processes. A recombinant human (rh)- 
PDGF dressing is available for use with standard DFU care, and rh-EGF in injectable 
form had positive effects in neuropathic vs ischaemic ulceration. Ointments containing 
enzymes such as papain, collagenase or fibrinolysin have been used for enzymatic 
debridement which promotes tissue granulation. The process of vacuum-assisted 
closure, where ideally a negative pressure of 125 mmHg is created over the wound area, 
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is effective in removing wound exudates and reducing oedema (Amin & Doupis, 2016). 
However, its use is contra-indicated with conditions such as necrosis, ischaemia and 
where deep tissues (tendons, bones, blood vessels) are exposed. Hyperbaric oxygen 
(HBO) therapy involves using oxygen at a higher than local atmospheric pressure. It has 
a host of benefits including reducing tissue hypoxia and oedema and increasing 
angiogenesis and fibroblast activity. It has been recommended by the European 
Committee for Hyperbaric Medicine for the management of DFUs. Stem cell therapy is 
also being investigated and has revealed beneficial effects on angiogenesis (Amin & 
Doupis, 2016). 
 
The International Working Group of the Diabetic Foot (IWGDF) systematically reviewed 
the effectiveness of different interventions used to treat chronic diabetic ulcers to guide 
treatment protocols. The overall picture is that very few interventions, from wound bed 
preparation, topical applications (including herbal preparations), compression therapy, 
surgical resection to skin grafts and more experimental treatments such as shockwave 
therapy are found to be effective for treating DFUs. The problem seems to be a lack of 
demonstrable effectiveness of these interventions or a lack of robust data due to study 
design issues. The IWGDF reached the conclusion that there is still no good evidence to 
justify the use of topical applications or dressing products for DFUs, indicating the great 
need for new treatments which have undergone rigorous testing (Game et al., 2016). 
 
2.4  In vitro Models to Assess Wound Healing 
2.4.1  The ‘scratch assay’ and wound healing 
Wound healing can be assessed in a variety of ways in vitro. One model that is frequently 
used is the ‘scratch assay’. Rodriguez et al., (2005) describes it as a ‘wound-healing 
assay’, and states that it is a simple and inexpensive method that imitates in vivo cell 
migration during wound healing. The premise of the scratch assay is based on the 
phenomenon that upon creating an artificial breach (a ‘scratch’) in the cell monolayer, 
cells on the edges of the scratch will move towards the gap to close it, eventually restoring 
cell-to-cell contacts (Liang et al., 2007).  
 
The methodology involves creating a ‘wound’ in a confluent monolayer of cells.  Images 
are then captured at the beginning, and at regular intervals during cell migration (closure 
17 
 
of the wound) and images are then compared to determine the rate of cell migration 
(Felice et al., 2015).  
 
Different cell types are used to create the monolayer including fibroblasts, epithelial or 
endothelial cells. It is most suitable for migration studies but has been combined with 
other techniques such as gene transfection or microinjection to track individual cells’ 
migration paths on the wound’s leading edge (Liang et al., 2007).  
 
There are a number of advantages of using the scratch assay. The first is its simplicity. It 
is probably the simplest way in which to study cell migration in vitro, and it only requires 
common and inexpensive equipment that is readily available in most cell culture 
laboratories. Another advantage is the fact that it mimics in vivo cell migration of different 
cell types e.g. fibroblasts will grow as loosely connected populations while endothelial 
cells will grow as sheets. Lastly, the scratch assay is particularly suited to studying the 
regulation of cell migration by cell-cell and cell-ECM interactions (Liang et al., 2007). 
 
Disadvantages include the fact that no chemical gradient is established, as in the case of 
the Boyden chamber assay. It is also more time-consuming than some other methods as 
one to two days are needed to form a cell monolayer and then 8 to18 h for cells to close 
the scratch. Finally, it may be resource intensive as large amounts of chemicals and cells 
are required for the assay, and as such it may not be suited to all studies (Liang et al., 
2007). 
 
2.5  Homeopathy 
2.5.1  Description 
According to the World Health Organization, ‘complementary medicine’ or ‘alternative 
medicine’ refers to health care practices outside a country’s conventional or traditional 
medicine and which are not fully integrated into the main health care system.  
 
Homeopathy is a complementary medicine system founded by Samuel Hahnemann in 
the late 18th century (Fisher, 2012). It is based on curing disease according to the principle 
of ‘like cures like’. It involves potentising - serially diluting and vigorously 
mixing/succussing – crude substances to create homeopathic remedies, which are used 
to treat a variety of disease conditions (Fisher, 2012). It is known as a gentle healing 
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modality due to its safety profile, and the risks associated with it are modest when 
compared to conventional medication (Kirby, 2002).  
 
There are many schools of homeopathy, among them ‘individualised’ or ‘classical’ 
homeopathy as well as ‘clinical’ homeopathy. Individualised homeopathy usually involves 
the prescription of a single medicine based on the patient’s complete array of mental, 
emotional and physical symptoms, while in clinical homeopathy, one or more 
homeopathic medicines are prescribed based on certain clinical diagnoses. Clinical 
homeopathy focuses more on physical symptoms than mental symptoms and more often 
involves the use of lower potencies, i.e. less dilute medicines such as the 3 cH, 5 cH and 
9 cH potencies (Fisher, 2012).  
 
‘Potency’ refers to the specific dilution of a homeopathic medicine that can range from 
raw plant extracts called ‘mother tinctures’ to ultra-diluted LM potencies (Jütte & Riley, 
2005). The distinction between ‘high’ and ‘low’ potencies is not clearly defined; however 
a practical boundary can be seen as the 12 cH  point or 24 X/D (a dilution of   10-24) which 
is the same dilution but expressed in decimal potency (X or D) instead of centesimal (C 
or cH) potency (Jütte & Riley, 2005).  
 
Homeopathy should not be confused with herbalism. Despite the fact that many of the 
crude materials used to make homeopathic medicines are plants or herbs, they are used 
in a highly diluted form in homeopathy and are prepared and prescribed differently to 
herbal medicines (Fisher, 2012).  
 
2.5.2  Homeopathic mother tinctures versus herbal tinctures and extracts 
In terms of clinical indications, there may often be no distinction between the use of herbal 
tinctures or extracts and homeopathic mother tinctures, especially as there is a large 
amount of overlap between traditional uses of substances. The main difference is in the 
rationale used to prescribe – whether the prescription is made according to the law of 
similars (homeopathic use) or according to phytotherapeutic literature (phytotherapeutic 
use) (Jütte & Riley, 2005).  
 
Herbal substances come in many forms and are produced using different manufacturing 
processes (Vlietinck et al., 2009). Herbal preparations can be primarily classified as 
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powdered/comminuted, herbal extracts, or dry extracts. Herbal extracts can then be 
further identified as liquid extracts/tinctures, semi-solid extracts or dry extracts. The 
difference between a liquid extract and herbal tincture is the ratio of herbal substance to 
solvent used for extraction. Liquid extracts are made by using 1 part of a plant with 1 to 2 
parts solvent, while tinctures are made using 1 part of a plant with 5 or 10 parts solvent 
(Vlietinck et al., 2009). 
 
It can be difficult to distinguish homeopathy from herbalism/phytotherapy when 
considering herbal extracts and homeopathic mother tinctures, because both are 
essentially liquid extractions made from plants in most cases. Mother tinctures are a 
mixture of plant juices and alcohol of a specified concentration, extracts of plants/plant 
parts or animal parts or secretions mixed with the specified liquid vehicle or nosodes 
(preparations derived from disease processes) (German Homoeopathic Pharmacopoeia, 
2012:H5.1). They are prepared according to manufacturing procedures stipulated in 
specific homeopathic pharmacopoeias (see Appendix A for manufacturing methods), 
which are different to the manufacturing methods used to make herbal preparations (Jütte 
& Riley, 2005).  
 
2.5.3 Calendula officinalis L. (C. officinalis) 
C. officinalis, or the pot marigold, has been widely studied and has a reputation for 
promoting wound-healing (Maver et al., 2015). The phytoconstituents found in this 
medicinal plant include triterpene glycosides, fatty acids, alcohols and flavonoids (Arora 
et al., 2013). C. officinalis has anti-pyretic, anti-tumour, cicatrising, anti-fungal and anti-
septic effects. It is used worldwide in various complementary medicine systems mainly in 
the treatment of skin conditions such as burns, cuts, rashes, varicosis, and ulcers, where 
it is usually prepared and applied in the form of an infusion, tincture or ointment (Arora et 
al., 2013).  
 
Calendula flower preparations are used in phytotherapy to treat wounds and burns, 
gastro-intestinal inflammatory disorders (in combination with other herbs), gingivitis and 
nappy rash (Braun & Cohen, 2010:283-284). It is revered for its non-irritant, antiseptic 
and healing properties and can be used both internally and externally (Braun & Cohen, 
2010:284).  
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Its anti-inflammatory effects are attributed to oleanane-type triterpene glycosides and 
triterpenoids, while its anti-oedema effects are due to faradiol esters (Muley et al., 2009). 
Wound healing effects, indicated by markers such as collagen-hydroxyproline and 
hexosamine and levels of acute phase proteins, may be due to decreased lipid 
peroxidation secondary to the antioxidant effect of C. officinalis (Muley et al., 2009).  
 
2.5.3.1 Wound healing effects of C. officinalis  
Several research studies have been conducted to investigate the wound healing effects 
of C. officinalis and these illustrate its great healing potential. Fronza et al., (2009) studied 
the effect of hexane and ethanolic extracts of C. officinalis on wound healing by using 
mice fibroblasts with the scratch assay and then evaluating wound closure by fluorescent 
microscopy. It was found that C. officinalis herbal extracts stimulated fibroblast 
proliferation and migration. Parente et al., (2012) used rats and a chorioallantoic 
membrane model to investigate the wound healing properties of an ethanolic extract of 
C. officinalis applied topically. They found that it had anti-inflammatory, antibacterial, 
angiogenic and fibroplastic properties. Tanideh et al. (2013) induced oral wounds in 
hamsters and tested the efficacy of a 5% and 10% C. officinalis gel application, which 
was applied once daily for five days. Animals treated with C. officinalis healed faster than 
control groups based on microscopic and macroscopic wound evaluation.  
 
Not much research has been completed on C. officinalis in homeopathic dilutions or 
potency, however existing results indicate a potential for increasing wound healing. C. 
officinalis is indicated in homeopathic texts for ulcers of the lower limb with pain and 
suppuration and for preventing necrosis (Hering, 1997:258) and Boericke (1999:156) 
states that it ‘promotes healthy granulation and rapid healing’. C. officinalis mother 
tincture is indicated for various septic-gangrenous conditions (Sinha, 1981:78). 
 
Bresler et al., (2007) used the scratch assay to determine the effects of C. officinalis 3 cH 
and PBM on wound healing in combination and singly, however a statistically significant 
effect was not found, despite encouraging cellular findings. Hostanska et al., (2012) 
investigated the wound healing properties of a homeopathic compound product 
containing C. officinalis 4 X/D (dilution of 10-4), Arnica montana 4 X/D, Hypericum 
perforatum 4 X/D and Symphytum officinale 6 X/D. They also included groups treated 
with this product diluted to 1/100 and 1/1000 with hydroethanol, which was either 
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succussed or not succussed. They used NIH 3T3 fibroblasts and assessed wound healing 
based on trans-well chamber migration and a commercially available wound healing 
assay kit using the scratch method. None of the preparations affected cell viability or 
influenced proliferation; however, fibroblast migration was increased with the non-diluted 
homeopathic product and it enhanced wound closure.  
 
2.5.4  Hypericum perforatum L. (H. perforatum) 
The major active ingredients found in St. John’s wort, or H. perforatum, are hypericin and 
hyperforin, while other constituents include phenylpropanes, flavonol glycosides, 
biflavones and proanthocyanidins (Nahrstedt & Butterweck, 1997). Research has 
revealed this plant possesses anti-depressant, anti-viral, anti-bacterial, anti-fungal and 
anti-cancer activity (Russo et al., 2014). It contains various substances that are anti-
microbial such as essential oils, phloroglucinols, flavonoids and tannins. It also acts 
directly on the capsids of viruses by inhibiting their mobility, and it has been shown to 
decrease the release of pro-inflammatory cytokine IL-6 and to inhibit NF-κB which is 
implicated in the development of cancer (Russo et al., 2014).  
 
H. perforatum is used in phytotherapy for psychiatric disorders such as depression, 
obsessive compulsive disorder, seasonal affective disorder and also for polyneuropathy, 
menopause, and herpes infection, and topically for atopic dermatitis, acute and contused 
injuries, myalgia and first-degree burns (Braun & Cohen, 2010:816-819). 
 
2.5.4.1 Wound healing effects of H. perforatum  
Several research studies have revealed its efficacy as a wound-healing agent. An olive 
oil preparation of H. perforatum was shown to increase wound healing, a statistically 
significant effect that was greater than that induced by olive oil alone. Süntar et al., (2010) 
induced a variety of wounds in rats, namely acetic acid-induced increase in capillary 
permeability, linear excision and circular excision wounds, and then evaluated wound 
healing based on tensile strength and histopathological markers of wound healing. The 
H. perforatum preparation increased re-epithelialisation and decreased inflammation.    
 
Han et al., (2017) tested the efficacy of H. perforatum on healing excisional wounds in 
rats. They used 50% H. perforatum oil cream and assessed wound healing through 
histological examinations and biochemical measures. Wounds healed faster with H. 
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perforatum use, which was ascribed to its ability to enhance epithelialisation and 
granulation.  
 
Topical application of H. perforatum has also been shown to increase wound healing in 
human clinical trials. Samadi et al., (2010) performed a double-blind, placebo-controlled 
randomised controlled trial (RCT) to determine the effects of H. perforatum on caesarean 
scars. The participants applied H. perforatum ointment to their scars three times a day for 
16 days. Wound healing was evaluated based on the REEDA scale (redness, oedema, 
ecchymosis, discharge, and approximation) which assessed these parameters. H. 
perforatum decreased pruritis and pain, increased wound healing and decreased scar 
formation.   
 
There is a lack of research on homeopathic preparations of H. perforatum. Homeopathic 
texts indicate its use for ‘open, painful wounds’ and for ‘injuries to parts rich in sentient 
nerves, particularly fingers and toes’ (Hering, 1997:128-129). H. perforatum mother 
tincture is indicated for injury to nervous tissue and the spine, and for punctured and 
lacerated wounds. It is indicated when the affected parts are excessively painful (Sinha, 
1981:87). Mohammadi et al., (2012) employed a sciatic nerve transection model in rats 
to determine the effect of homeopathic H. perforatum on peripheral nerve regeneration. 
H. perforatum in 30 cH potency was administered twice daily for a week after the surgical 
procedure. Rats treated with H. perforatum had faster and better regeneration of axons 
and greater recovery of myelinated fibers compared to sham operation and control 
groups. A systematic review by Raak et al., (2012) concluded that H. perforatum is 
successful for treating dental problems such as post-operative pain, swelling and 
neuropathic pain, based on expert opinion and single case studies. However, study 
results are heterogenous, and more rigorous research is needed to draw reliable 
conclusions.  
 
2.5.5  Echinacea purpurea (L.) Moench (E. purpurea) 
The purple cone flower, or E. purpurea, is part of the Asteraceae family and is a perennial 
medicinal herb (Manayi et al., 2015). It is especially well-known for treating cold 
symptoms, due to its anti-inflammatory and immunostimulatory effects. It has complex 
chemical constituents including alkamides, ketoalkenes, caffeic acid derivatives, 
polysaccharides and glycoproteins (Manayi et al., 2015). 
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Its immunomodulatory effects are based on the main mechanisms of phagocyte 
activation, fibroblast stimulation and enhanced leucocyte mobility secondary to increased 
respiratory activity (Manayi et al., 2015). Research suggests it increases innate immunity 
and enhances the actions of natural killer cells, polymorphonuclear leucocytes, 
neutrophils and macrophages. E. purpurea extract has potent anti-inflammatory effects, 
reduces expression of pro-inflammatory cytokines in vitro and ameliorates the symptoms 
of atopic eczema when applied topically (Oláh et al., 2017).  
 
The clinical uses of herbal E. purpurea are for upper respiratory tract infections, wound 
healing, herpes infection, reducing chemotherapy side effects, halitosis and recurrent 
candidiasis. It is commonly used to treat infections and to prevent contracting them (Braun 
& Cohen, 2010:394-395).  
 
2.5.5.1 Wound healing effects of E. purpurea 
It has also been investigated in the context of wound healing to some extent, such as in 
arsenic-induced skin necrosis. Rezaie et al., (2013) created wounds in rats using 
subcutaneous arsenic and tested the effect of E. purpurea herbal extract on healing. 
Histopathological data revealed increased granulation tissue and angiogenesis in the rats 
that received E. purpurea intraperitoneally.  
 
In a clinical trial, Kim et al., (2002) tested the effects of a combined herbal extract of E. 
purpurea and Echinacea angustifolia (E. angustifolia) on participants over a four-week 
period. Besides improving their overall physical health and wellbeing, it increased the 
complement properdin, which could indicate activation of the complement immune 
system. They also found decreased TNF-α in this group, however, could not draw firm 
conclusions from these findings due to a large variety in participants’ baseline values.  
 
There is a dearth of data on homeopathic preparations of E. purpurea in the field of wound 
research. The use of E. purpurea is indicated in homeopathic texts for ‘septic conditions 
in general’ and for ‘old tibial ulcers’ and gangrene, and these indications are the same for 
the mother tincture (Boericke, 1999:264). One study using an animal model of induced 
peritonitis found that a D4 (a dilution of 10-4) dilution of E. angustifolia had a protective 
effect against dexamethasone-induced toxicity in peritoneal leucocytes (Pedalino et al., 
24 
 
2004). It also increased counts of neutrophils. There was a small but significant increase 
in phagocytosis in groups treated with an ‘accord of potencies’, namely a mixture of 
different dilutions of E. angustifolia (Pedalino et al., 2004). 
 
2.6  Photobiomodulation  
2.6.1  Description and background 
PBM, formerly referred to as low-level laser therapy (LLLT) or phototherapy, is the use of 
photons at non-thermal irradiance to modify biological activity (Avci et al., 2013). Coherent 
light sources (lasers) or non-coherent light sources such as filtered lamps, LEDs or 
sometimes both are used for PBM/LLLT. It is referred to as ‘low-level’ laser therapy to 
differentiate it from other forms of laser treatment which have a higher power and are 
used for applications such as ablation, cutting or thermally coagulating tissue (Avci et al., 
2013). PBM/LLLT does not release energy in the form of heat, sound or vibration. Thus, 
it causes a non-thermal reaction. In contrast, high-energy lasers cause increases in 
temperature so severe, they can damage or even vaporise cells (AlGhamdi et al., 2012).  
 
Light therapy is by no means a new invention – sunlight has been used for thousands of 
years by civilisations in Egypt, India and China to treat skin conditions (Barolet, 2008). 
Niels Ryberg Finsen, a Danish physician and scientist who won the Nobel Prize in 
Physiology or Medicine in 1903 for his work, rediscovered solar therapy more recently. 
This event marks the beginning of phototherapy which involves using an artificial radiation 
source. It was only later, in the late 1960s that Hungarian physician Endre Mester started 
experimenting with a low-powered ruby laser (694 nm) to investigate the carcinogenic 
effects of lasers in mice (Barolet, 2008). He was surprised by his results – laser treatment 
improved hair growth on the animal’s shaved back; this was the first instance of PBM 
which paved the way for a new field of study (Barolet, 2008). Medical research using both 
lasers and LEDs has grown since that time and is now used for treating various medical 
conditions.  
 
Red-beam or near-infrared (NIR) lasers, with 600-1 100 nm wavelengths and 1-500 mW 
output power, are often used for PBM (AlGhamdi et al., 2012). The radiation energy 
consists of a continuous wave or pulsed light with a constant beam of a relatively low 
energy density (0.04 to 50 J/cm2). The power of the laser directed at the cells is measured 
in milliwatts (mW) (AlGhamdi et al., 2012). Not all ‘low-level’ applications of laser are 
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equal. The success of PBM depends on its wavelength, power, dose and application time 
(Andrade et al., 2014). Doses between 3 and 6 J/cm2 seem to be more effective, with 
beneficial effects like stimulating cellular proliferation while doses exceeding 10 J/cm2 
have suppressive or even harmful effects (Andrade et al., 2014; AlGhamdi et al., 2012).  
 
2.6.2 Molecular mechanisms of photobiomodulation 
The healing effects of PBM are ascribed to its ability to decrease inflammation and pain 
and promote tissue repair, while preventing tissue damage. Exposing tissues to low levels 
of red or NIR light can activate or depress a variety of cellular processes such as 
increasing blood flow and changing the cellular redox state (Avci et al., 2013). The 
mechanisms of action of PBM are not yet fully understood; however, knowledge has been 
increasing in recent years and several theories exist (Avci et al., 2013). 
 
The main hypothesis involves the enzyme COX which forms part of the mitochondrial 
respiratory chain (De Freitas and Hamblin, 2016). COX is a photo-acceptor (or 
chromophore) and transduces photosignals in the red and NIR wavelengths of the light 
spectrum. It is thought that photons from PBM dissociate inhibitory nitric oxide (NO) from 
COX and in this way increase electron transport, mitochondrial potential and production 
of ATP (Figure 2.3) (De Freitas and Hamblin, 2016). Many studies have demonstrated 
that PBM reduces COX expression, which is used as a marker of inflammation (Hamblin, 
2017).  However, some studies indicate differences in the expression of COX-1 and COX-
2; for instance, De Almeida et al., (2011) found that PBM using 1.0 J can protect skeletal 
muscle against exercise-induced damage and inflammation, and that this effect can be 
ascribed to increased mRNA expression of COX-1 but decreased expression of COX-2.  
 
Another theory is that light-sensitive ion channels are activated by PBM, which allows 
calcium entry into the cell. In addition, it has been shown that photon absorption activates 
various signalling pathways by means of ROS, cyclic adenosine monophosphate (cAMP), 
NO and calcium which activates transcription factors. This can cause increased 
expression of genes involved in protein synthesis, cell migration and proliferation, anti-
inflammatory pathways, anti-apoptotic proteins and antioxidant enzymes. In addition, 
various cell types and tissues such as brain, muscle and nerve tissue respond to PBM 
and it is apparent that stem cells and progenitor cells are especially susceptible to its 
effects (De Freitas & Hamblin, 2016). 
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Fibroblasts also exhibit changes in response to PBM. Ayuk et al., (2016) used WS1 
fibroblasts to investigate changes in gene expression of cell adhesion molecules after 
laser irradiation at 830 nm with a dose of 5 J/cm2. They found that PBM modulated the 
expression of various genes related to ECM production in both ‘diabetic’ wounded and 
‘normal’ wounded models, which emphasises the importance of ECM-related molecules 
in wound healing. These results correlate with this group’s previous findings using 
irradiation at 660 nm (Ayuk et al., 2014) and also in diabetic cells where 25 of 64 genes 
were significantly down-regulated and 10 were significantly up-regulated following PBM 
(Houreld et al., 2018). Mignon et al., (2018) found that irradiation with short wavelength-
light (≤530 nm) inhibited metabolic activity in dermal fibroblasts, while longer wavelength 
irradiation (≥590 nm) had a neutral effect. Irradiation with NIR light at 850 nm wavelength 
and a dosage of 20 J/cm2 stimulated metabolic activity without an increase in ROS 
production.  
 
2.6.3 Photobiomodulation as a therapeutic intervention 
 PBM is used for medical applications and cosmetically such as for treating fine wrinkles, 
photo-aged skin, or scars, using a process called photorejuvenation. It is effective in 
treating a variety of dermatological conditions including acne, burns, hypertrophic scars 
and herpes virus lesions. The development of LED devices has made PBM more 
accessible as a treatment option, as they eliminate some of the concerns associated with 
lasers, namely expense, safety and trained personnel to administer treatment. LED 
Figure 2.3: The proposed mechanisms of photobiomodulation (Ao et al., 2018). 
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devices are convenient, and home-use devices are now widely available (Avci et al., 
2013). 
 
Experimental studies have revealed the wound healing effects of PBM. Al-Watban and 
Andres (2000) completed in vitro studies using a 632.8 nm helium-neon (HeNe) laser on 
various cell lines and in vivo studies using different wavelengths of laser on oval full-
thickness wounds in rats. They found that application of laser accelerated wound healing 
by 29% when animals were treated with a HeNe laser of 632.8 nm. In addition, their cell 
culture investigations showed laser exposure stimulated, inhibited or had zero effect on 
the growth of different cell types, dependent on the dose of the laser. However, the levels 
of laser exposure at which these effects took place differed between cell lines.  
 
Maiya et al., (2009) tested the wound healing capacity of a 632.8 nm HeNe laser (3 to 9 
J/cm2) in a diabetic rat model. Circular wounds were made and treated with laser for five 
days a week until wounds were healed and compared to wounds in rats that received 
sham irradiation. Wound healing was greatly accelerated by laser treatment, and 
furthermore this effect was greatest at a dose of 4 to 5 J/cm2, while doses of 7 to 9 J/cm2 
delayed healing slightly. Laser treatment significantly increased wound contraction and 
hydroxyproline, a constituent of collagen.  
 
Human trials confirm this data. In an RCT by Hopkins et al., (2004), wounds were created 
on the forearms of 22 participants and subsequently treated with PBM at a wavelength of 
820 nm and dosage of 8 J/cm2. Wounds were monitored at set time intervals until twenty 
days after injury. They found that PBM facilitated faster wound healing than in the sham 
group, and participants treated with laser had increased wound contraction (Hopkins et 
al., 2004). A double-blind clinical trial by Ramos et al., (2019) showed the healing effects 
of PBM on post-operative scars. Participants with abdominoplastic scars received ten 
sessions of 520, 590 and 645 nm wavelength and 10 J/cm2 dose PBM on the right side 
of their scars while the left side served as a control. Six months after surgery, scar tissue 
treated with PBM had significantly improved quality based on the Vancouver Scar Scale, 
Patient and Observer Scar Assessment Scale and photographic records.  
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2.6.4 Photobiomodulation for treating diabetic foot ulcers 
The healing effect also applies in the context of hyperglycaemia. Houreld et al., (2018) 
created a diabetic wound model by continuously growing fibroblasts in media with added 
glucose. They found that PBM using irradiation at a wavelength of 660 nm and 5 J/cm2 
dosage modulates gene expression of various cell adhesion molecules, illustrating one 
mechanism by which laser therapy increases wound healing. In other similar studies, it 
was found that laser irradiation with 660 nm or 830 nm at a dose of 5 J/cm2 significantly 
increased collagen type 1 and TIMP proteins and decreased MMP-3 and MMP-9 in 
diabetic wounded fibroblasts (Ayuk et al., 2018). Jere et al., (2018) investigated the 
effects of PBM (660 nm, 5 J/cm2) in the same model to establish the role of certain 
signalling pathways in wound healing. They found that PBM significantly increased EGF 
levels, activation of its receptor (p-EGFR) as well as the Janus kinase/Signal transducer 
and activators of transcription (JAK/STAT) pathway which together indicates stimulation 
of cellular proliferation and migration.   
 
Kaviani et al., (2011) tested the effect of PBM on chronic, non-ischaemic DFUs and found 
that it fast-tracked healing. The mean healing time for patients receiving PBM with 
irradiation of 685 nm wavelength and 10 J/cm2 dose was 11 weeks compared to 14 weeks 
in the placebo group, a difference that did not reach statistical significance at this time 
point. However, at four weeks there was a statistically significant decrease in ulcer size 
in the PBM group. PBM using a pulsed wave laser at 890 nm irradiation with 0.324 J/cm2 
decreased microbial flora in the wound bed and enhanced the biomechanical properties 
of wounds in an animal model of Type 2 DM (Asghari et al., 2017). In another animal 
study of hyperglycaemia, PBM treatment (843 nm wavelength, 5.7 J/cm2 dosage) 
significantly decreased the area of inflammatory infiltrates in abdominal adipose tissue in 
mice over a period of four weeks, as well as significantly decreased blood glucose levels 
24 h after irradiation (Yoshimura et al., 2016).  
 
Carvalho et al., (2016) investigated the efficacy of C. officinalis oil and PBM for treating 
DFUs in an RCT of 32 patients. They used a 658 nm laser with a dose of 4 J/cm2 and 
irradiated the wounds three times weekly for a total of 12 sessions. Wounds were washed 
with 5 mL C. officinalis oil for 30 days in the group receiving C. officinalis alone, and in 
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the combination group, the laser protocol was applied together with C. officinalis oil. PBM 
applied singly or with C. officinalis significantly decreased pain and the wound area.  
 
An animal model of diabetes was used to evaluate PBM effects on collagen production 
and organisation as well as mitochondrial dynamics (Tatmatsu-Rocha et al, 2018). PBM 
up-regulated collagen production, improved angiogenesis as well as VEGF production. It 
also had beneficial effects on mitochondrial fission-fusion balance and inflammation.  
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CHAPTER 3  
MATERIALS AND METHODS 
3.1 Project Approval 
This research project was approved by  the Higher Degrees Committee of the Faculty of 
Health Sciences of the University of Johannesburg (clearance number HDC-01-11-2019, 
Appendix B) and by the Research Ethics Committee of the Faculty of Health Sciences of 
the University of Johannesburg (Ethics number REC-01-19-2019, Appendix C. The study 
was conducted at the Laser Research Centre (LRC) (see Appendix D for permission 
letter) of the University of Johannesburg. Details of materials, reagents and calculations 
used are shown in Appendix E. 
 
3.2 Experimental Design 
A summary of the experimental design can be seen in Figure 3.1. This was a quantitative 
experimental study using an in vitro model.  
 
3.3 Cell Culture  
3.3.1 Reconstitution of frozen fibroblasts 
Commercially available human skin fibroblasts (WS1, American Type Culture Collection 
or ATCC CRL-1502, Appendix F) were used as an in vitro model in this study. Stocks 
of these cells are available in the LRC and are stored in liquid nitrogen, which allows them 
to remain viable indefinitely. Frozen stocks, which contained 1 X 106 cells, were removed 
from the liquid nitrogen and thawed by partially submerging the cryovial in a 37°C water 
bath until a small amount of ice remained. The outside of the vial was sterilised with 70% 
ethanol (EtOH) and placed inside the Class II biological safety cabinet, in which all tissue 
culture work was performed to prevent contamination. Cells were added dropwise into a 
75 cm2 flask containing 15 mL pre-warmed supplemented medium using a disposable 2 
mL pipette. Cells were incubated for 24 h after which the flask was viewed using an 
inverted microscope (Wirsam Scientific, Olympus CKX41) to ensure attachment and the 
medium containing cryoprotectant agent (Biofreeze) removed and replaced with pre-
warmed supplemented medium. 
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3.3.2  General cell culture  
Cells were incubated in an incubator set at 37°C, 5% carbon dioxide (CO2) and 85% 
humidity. They were cultured in Minimum Essential Medium (MEM), supplemented with 
10% foetal bovine serum (FBS), 1 mM sodium pyruvate, 2 mM L-glutamine, 0.1 mM non-
essential amino acids (NEAA), 1% Penicillin-Streptomycin (100 units Penicillin, 0.1 
Figure 3.1: Experimental design. 
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mg/mL Streptomycin) and 1% Amphotericin-B (2.5 µg/mL) in 75 cm2 or 175 cm2 culture 
flasks. Details of these reagents are shown in Appendix E1. Cells between passage 
number 11 and 16 were used in experiments.  
 
Flasks were viewed daily using an inverted microscope to determine cell density and to 
confirm the absence of microbial or other contamination. When a confluence of 70-80% 
was reached cells were detached and either used for experimental assays, sub-cultured 
or frozen as stock. Medium was removed from the flask by aspiration and discarded in a 
waste container with 10% sodium hypochlorite (JIK). The cell monolayer was rinsed with 
10 mL pre-warmed Hanks’ Balanced Salt Solution (HBSS) and the dissociation agent 
TrypLE™ Select added (1 mL per 25 cm2) to detach cells from the flask surface. The 
flask was incubated at 37°C for 5 min then tapped gently to encourage cells to detach, 
after which the flask surface was viewed to ensure complete detachment. The cell 
suspension in TrypLE™ Select was removed and transferred to a 50 mL Falcon tube, 
and the flask was rinsed with HBSS which was also added and then centrifuged for 5 min 
at 2 500 rotations per minute (rpm) (Heraeus Megafuge 16R, Thermoscientific). The 
supernatant was discarded, and cells resuspended in 5 mL pre-warmed HBSS and a cell 
count performed as described below in the ‘Trypan Blue’ assay. The cell suspension was 
centrifuged again for 5 min at 2 500 rpm and further used as described.  
 
3.3.3 Sub-culture of cells  
Cells were resuspended in 5 mL pre-warmed supplemented medium after re-
centrifugation and transferred to 175 cm2 flasks containing 50 mL pre-warmed 
supplemented medium using a 10 mL disposable pipette. The flask was gently swirled to 
ensure uniform distribution of cells before being sprayed with 70% EtOH and placed in 
the incubator.  
 
3.3.4  Freezing of cells 
Cells were frozen according to the following method to ensure adequate cell stocks. After 
re-centrifugation the supernatant was discarded, and the cell pellet resuspended in 1 mL 
of cryoprotective medium (Biofreeze) at a density of 1 X 106 cells per mL and transferred 
to 2 mL cryoprotective vials. Cryovials were transferred to the CoolCell™ freezing 
container (Biocision) which ensures slow freezing of cells to enhance post-thaw cell 
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viability, and immediately placed in a -20°C freezer for 1 h, then at -80°C overnight after 
which vials were transferred to liquid nitrogen for indefinite storage.  
3.3.5  Creating ‘small plates’ for experiments 
Cells were seeded into 3.4 cm diameter tissue culture plates for all experimental assays. 
The supernatant was discarded and cells were resuspended in 5 mL pre-warmed HBSS. 
The amount of plates that could be seeded from one flask was calculated (Appendix 
E2.4). Cells were seeded at a density of 6 X 105 cells per plate in 3 mL medium and 
allowed to attach overnight. The next morning the medium was removed, cells rinsed with 
500 µL HBSS and 2 mL fresh medium was added to culture plates.  
 
3.4 Cell Models  
There were three main cell models: normal (unstressed), wounded (subjected to the 
scratch assay) and diabetic wounded (grown under hyperglycaemic conditions and 
subjected to the scratch assay). An extra alcohol control group was added to determine 
the effects of the vehicle used for the homeopathic solution (see 3.6.4). 
 
3.4.1 Diabetic cell model 
A diabetic cell model was achieved by continuously growing cells (37°C, 5% CO2, 85% 
humidity)in a hyperglycaemic environment; cells were cultured in complete medium 
(containing 5.6 mMol/L glucose) with an additional 17 mMol/L D-glucose added to achieve 
a final glucose concentration of 22.6 mMol/L (Houreld & Abrahamse, 2007). To achieve 
this, 0.9 mL of the 1 M stock D-glucose solution was added to 49.1 mL of complete 
medium. 
 
3.4.2 Wounded cell model 
Wounded cell models were created by using the ‘scratch assay’ (Felice et al., 2015), 
where a disposable 1 mL pipette was used to scrape the confluent cell monolayer in a 
straight line, removing cells in the centre of the plate to create a cell-free ‘wound’. Cells 
were allowed to adjust to the wounding process for 30 min at 37°C, 5% CO2, 85% humidity 
before further treatment, if any, was performed.  
 
3.5 Photobiomodulation 
Photobiomodulation was completed by using a laser supplied by the CSIR National Laser 
Centre (NLC) of South Africa. A continuous wave diode laser (FC-655-300-MM2-SMA-1-
34 
 
0; RGBlase, LLC, California, USA), which emits at a wavelength of 660 nm, was used. 
The laser parameters are summarised in Table 3.1 below. The temperature of the culture 
medium in the plates did not drop below 32°C as previously demonstrated (Ayuk, 2012). 
Non-irradiated cells (0 J/cm2) were used as controls. Culture plates with a diameter of 3.4 
cm were irradiated from above, with the lid of the plate removed and in darkness. 
Irradiation was achieved via fibre optics, at a distance that created a spot size of exactly 
the same area as the culture plate. 
 
                               Table 3.1. Laser parameters. 
Light source Diode laser 
Wavelength  660 nm 
Emission type Continuous wave 
Power output 100 mW 
Power density  11 mW/cm2 
Spot size 9.1 cm2 
Dose 5 J/cm2 
Irradiation time 7 min 34 s 
Energy 45.4 J 
 
The exposure time to laser light had to be calculated according to the measured output, 
which was done before each irradiation (Figure 3.2). A power meter (FieldMate Laser 
Power Meter, Coherent) was used to measure power output at bench level in the dark, 
before irradiating cells. The calculation shown below was used to determine exposure 
time. In the calculation ‘X’ indicates power output measured in mW.  
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Following irradiation, cells were incubated (37°C, 5% CO2) for 48 h and digital images 
captured at the 0 h time point (directly following radiation), and at 24 and 48 h thereafter. 
After 48 h the required amount of culture medium was removed and used for the LDH 
assay, and the rest frozen at -80°C for performing the ELISA assays at a later stage. Cells 
were detached, resuspended and used for the Trypan Blue and ATP assays as described 
below.  
 
3.6 Homeopathic Solution 
3.6.1  Determining solvent for homeopathic solution 
A preliminary experiment was performed to choose the best solvent to use for the 
homeopathic solution. As homeopathic remedies are usually prepared in EtOH, a non-
toxic effect had to be established before continuing with further experiments. Different 
concentrations of EtOH were tested as a solvent for the homeopathic solution by using a 
3 cH solution prepared in respectively distilled water (0% EtOH), 2.5% EtOH, 5% EtOH 
and 10% EtOH (see Appendix A for manufacturing methods). These were tested on WS1 
fibroblasts according to the methodology of Bresler et al., (2007). For this experiment 6 X 
105 cells were seeded in 3.4 cm diameter culture plates, the scratch assay was 
performed, cells allowed to acclimatise for 30 min after which 30 µL of the homeopathic 
solution in the various concentrations EtOH was added. Cellular morphology, Trypan 
Blue, LDH membrane integrity and ATP luminescence assays were performed as 
described below to determine cellular responses.  
 
Figure 3.2: Laser exposure time calculation. 
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3.6.2 Homeopathic solution 
A 3 cH homeopathic compound solutioncontaining C. officinalis, H. perforatum and E. 
purpurea prepared in 5% EtOH was used for the homeopathic solution. The 3 cH solution 
is a low potency homeopathic medicine which is well-suited to the clinical nature of the 
treatment of diabetic wounds and has been utilised before in this kind of study (Bresler et 
al., 2007), The solution (30 µL) was added to plates containing 2 mL complete medium 
using a sterilised pipette tip, which resulted in a final EtOH concentration of 0.074% in a 
total volume of 2,030 µL . This was done 30 min after the wounding protocol. 
 
3.6.3 Combination treatment 
In models receiving both homeopathic and laser treatment, the homeopathic solution was 
added first as described in 3.6.2, and then cells were irradiated as described in 3.5. 
 
3.6.4 Alcohol control 
A 5% EtOH solution was used for the alcohol control models. Cells were wounded and 
allowed to adjust for 30 min, after which 30 µL of EtOH was added to plates containing 
2 mL complete medium, which resulted in a final EtOH concentration of 0.074% in the 
medium. 
 
3.7  Methods to Determine Cellular Responses 
3.7.1 Cellular morphology 
Images of the monolayer were obtained at 0, 24 and 48 h after treatment to observe 
morphological changes in all cell models. The 0 h images were captured directly after 
irradiation, or after treatment (if any). To achieve this, an inverted light microscope 
(Wirsam Scientific, CKX41) coupled to a digital camera (Olympus, SC30) was used 
together with AnalySIS getIT software. Images were taken using the 4X objective, with 
the plate lid removed and in the dark.  
 
3.7.2  Trypan Blue exclusion assay 
This method is based on the principle of dye exclusion – live or viable cells are 
impermeable to the Trypan Blue dye, whereas dead or non-viable cells take up the dye 
due to membrane damage. Cells were detached by adding 500 µL pre-warmed TrypLE™ 
Select to each plate and incubating (37°C, 5% CO2) for 5 min. Cells were resuspended 
in 1 mL of serum free medium after centrifugation at 2 500 rpm for 5 min using a bench 
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centrifuge (Biofuge Pico Heraeus, D37520). Cell suspension (10 µL) was added to a 
0.5 mL Eppendorf tube and then 10 µL of 0.4% Trypan Blue was added to stain cells. 
The mixture was gently mixed by pipetting and then 10 µL added to each chamber of a 
re-usable plastic cell counter slide, and the sample allowed to settle for 30 s to allow for 
equal distribution of cells. The Countess® II FL (Invitrogen) was used to obtain the 
percentage of live cells after ensuring optimal focus and illumination. This instrument 
captures an image and analyses it to generate the total number of cells, and the number 
and percentage of viable and non-viable cells. An average of 2 readings was used.   
 
3.7.3  Lactate dehydrogenase (LDH) membrane integrity assay 
The CytoTox 96® Non-Radioactive Cytotoxicity Assay was used to quantify LDH. The 
amount of LDH released reflects the amount of membrane damage and thus cellular 
toxicity, as normal, non-damaged cell membranes are impermeable to LDH, but 
damaged membranes allow leakage of LDH into the extracellular fluid (culture media). 
This is a colorimetric assay where LDH reacts to convert a tetrazolium salt into a red 
formazan product which can be measured to indicate the number of lysed cells.  
 
Reconstituted substrate mix (50 µL) was added to each well of a clear 96-well plate. 
Complete medium (50 µL), which had not been used to culture cells in, was added to 
two wells with substrate mix to serve as a background control. Then 50 µL of culture 
medium from experimental plates were added to the rest of the wells containing 
substrate mix. Plate contents were gently mixed by tapping the side of the plate. The 
plate was covered with foil and incubated in the dark at room temperature for 30 min. 
Then 50 µL Stop Solution was added to each well, any large air bubbles were burst, and 
absorbance was detected by using a multiplate reader (Perkin-Elmer, Victor3, 1420 
Multilabel counter) set to 490 nm, with the exposure time set to 1 s. The average 
background control reading was subtracted from all experimental values. 
 
3.7.4  Adenosine triphosphate (ATP) luminescence assay 
The CellTiter-Glo® 3D Cell Viability Assay was used to determine viability in metabolically 
active cells or viable cells. In this assay thermostable luciferase is used to generate a 
stable luminescent signal, while inhibiting endogenous enzymes released during cell lysis 
which can give inaccurate results. The luminescent signal is proportional to the amount 
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of ATP present, which in turn is directly proportional to the number of viable cells present 
in culture.  
 
Cells were detached by adding 500 µL pre-warmed TrypLE™ Select to each plate, and 
incubated (37°C, 5% CO2) for 5 min. Cells were resuspended in 1 mL of complete culture 
medium after centrifugation at 2 500 rpm for 5 min using a bench centrifuge (Biofuge Pico 
Heraeus, D37520). Complete culture medium (50 µL), which had not been used to 
culture cells in,  was added to two wells of an opaque-walled 96-well plate to serve as 
a background control. Then 50 µL of cell suspension was added to the relevant wells, 
and 50 µL of the CellTiter-Glo® 3D reagent was added to each well. The plate was 
covered in foil and placed on an orbital shaker (Polymax 1040, Heidolph Instruments) 
for 10 min. Luminescence (in Relative Light Units or RLU) was measured using a 
multiplate reader (Perkin-Elmer, Victor3, 1420 Multilabel counter). The average 
background control reading was subtracted from all experimental values.  
 
3.7.5  IL-6 and TNF-α ELISA  
The enzyme linked immunosorbent assay (ELISA) is a plate-based methodology used 
to quantify levels of target molecules such as proteins in samples, by binding to specific 
antibodies. ELISAs were performed according to the manufacturer’s instructions to 
quantify levels of the pro-inflammatory cytokines IL-6 and TNF-α present in culture 
media. Both kits are based on the Sandwich-ELISA principle and made use of plates 
that were pre-coated with antibodies specific to IL-6 and TNF-α respectively. The 
procedure to complete both assays was the same.  
 
Culture media samples obtained previously were thawed and centrifuged for 20 min at 
1 000 g at 8°C. The supernatant was decanted and further used for the assays. Standard 
working solution (provided) or sample (100 µL of either) was added to each well. The 
plate was covered and incubated for 90 min at 37°C. The liquid was removed and 100 µL 
Biotinylated Detection Ab working solution added to each well, the plate was covered, 
well contents gently mixed and the plate incubated for 1 h at 37°C. The solution was 
then decanted from wells and 350 µL wash buffer added to each well and discarded, 
using an automated plate washer (Bio-Rad, PW40). This washing step was repeated 
twice more. HRP Conjugate working solution (100 µL) was added to wells, the plate 
covered and incubated for 30 min at 37°C. The solution was decanted, and wells 
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washed three times as described above. Then 90 µL Substrate Reagent was added to 
wells, the plate covered and incubated for 15 min at 37°C in the dark. Stop Solution 
(50 µL) was added to each well and Optical Density (OD) read at once using a plate 
reader set to 450 nm (Perkin-Elmer, Victor3, 1420 Multilabel counter).  Experimental 
results were obtained by comparing values to the generated standard curve, after 
subtracting the standard zero OD value.  
 
The standard curve (Figure 3.3 and 3.4) for IL-6 and TNF-α was generated by 
calculating the mean OD of the two wells for each of the standard concentrations and 
then subtracting the mean zero OD value (only sample buffer added to wells) from these 
values. An XY scatter plot was drawn with concentration on the X-axis and OD on the 
Y-axis. A line of best fit was inserted, and the equation of the line displayed. The 
equation, together with the known OD values were used to calculate concentration of 
protein (IL-6 or TNF-α).  
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Figure 3.3: IL-6 standard curve (8 point serial standard curve ranging from 0 to 500 
pg/mL). 
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3.8  Reliability and Validity Measures 
Measures to ensure quality results were taken; these were to repeat all experiments a 
minimum of 3 times (n=3) and to include control groups for all the experiments. Assay 
results were based on duplicate measures where possible. Established experimental 
protocols were followed according to the research group’s and manufacturers’ guidelines, 
and the homeopathic solution as well as the alcohol was manufactured and/or supplied 
by a reputable homeopathic company (Fusion Homeopathics, South Africa). They 
manufactured the solution according to established German Homeopathic 
Pharmacopoeia methods (German Homoeopathic Pharmacopoeia, 2012) and kept 
detailed records of all steps of the manufacturing process. A commercially available cell 
line obtained from ATCC were used for all experiments. 
 
3.9 Data Collection and Analysis 
Data were captured on the day of the experimental procedure using Microsoft Excel and 
further data analysis was done using Sigma plot software (version 25). All statistical 
analyses were completed with the help of a statistician from STATKON (Kuhudzai, 2019). 
The student t-test was used to determine differences within groups and one-way analysis 
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Figure 3.4: TNF-α standard curve (8 point serial standard curve ranging from 0 to 
500 pg/mL). 
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of variance (ANOVA) with the Tukey post-hoc test was used to detect differences 
between group means. P values < 0.05 were regarded as statistically significant. 
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CHAPTER 4 
RESULTS 
4.1 Determining Solvent for Homeopathic Solution 
The best solvent concentration to use for the homeopathic solution had to be determined 
as a high EtOH concentration may be cytotoxic to the cells in vitro. Three different 
concentrations were tested (2.5%, 5% and 10%) in a normal wounded cell model, and 
distilled water was used as a control (dH2O). The EtOH was added to culture medium to 
give final EtOH concentrations of 0.037%, 0.074% and 0.148%, respectively. Cellular 
morphology, viability (Trypan Blue staining and ATP luminescence) and cytotoxicity (LDH 
assay) were used to determine the optimal EtOH concentration to employ in further 
assays.  
 
4.1.1 Cellular morphology 
Morphological changes were examined at 0, 24 and 48 h in normal wounded cells 
incubated with C. officinalis, H. perforatum and E. purpurea prepared in 2.5%, 5% and 
10% EtOH using inverted light microscopy. Cells appeared large, flat, and spindle-shaped 
(stretched), with numerous projections extending out from the ends of the cell body. The 
central scratch, or ‘wound’, was visible as an area in the centre of the tissue culture dish 
with cells on either side. As time progressed, cells could be seen migrating and moving 
towards the central scratch in all the various models (Figure 4.1). Migration was more 
rapid over the 48 h incubation period in cells treated with 5% EtOH, with more cells 
present in the central scratch as compared to those treated with 2.5% and 10% EtOH, 
and even the dH2O group.   
 
4.1.2 Cellular viability 
Cellular viability was determined by Trypan Blue staining and ATP luminescence 24 h 
after adding the homeopathic solution. There was no significant difference in percentage 
cell viability (Figure 4.2) and ATP luminescence (Figure 4.3) between the control model 
(dH2O) and remedies prepared in 2.5%, 5% and 10% EtOH respectively. 
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Figure 4.1: Morphology of normal wounded cells treated with homeopathic remedy (H) 
prepared in different ethanol (EtOH) concentrations (2.5%, 5% and 10%). Cells can be seen 
migrating into the central scratch (wound), with cells migrating at a more rapid rate when 
treated with homeopathic solution in 5% EtOH. Scale bars = 200 µm. n=3 
Figure 4.2: Percentage cellular viability as assessed by the Trypan Blue exclusion assay 
(Mean±SD). Models assessed were normal wounded cells to which homeopathic remedy 
(H) prepared in distilled water (dH2O), 2.5% ethanol (2.5%), 5% ethanol (5%) and 10% 
ethanol (10%) was added. No significant differences were found. n=3 
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4.1.3 Cytotoxicity 
Cytotoxicity was determined by measuring LDH which leaked out of damaged cells into 
the culture media (Figure 4.4). Cytotoxicity data shows there was a significant increase 
in the release of LDH into the culture media in all three EtOH groups (2.5%, 5% and 10%, 
respectively) compared to the control (dH2O) group. 
 
Based on these results, an EtOH concentration of 5% was selected as the solvent for the 
homeopathic solution for further studies. This corresponds with the work of Bresler et al. 
(2007) who also found that an alcohol concentration of 5% was ideal as it produced the 
greatest degree of cell migration with minimal cell death at 48 h.  
 
4.2 Experiments 
4.2.1 Cellular morphology 
Cellular responses to the various treatment conditions were determined qualitatively by 
comparing morphology at 0 h, 24 h and 48 h after wounding. Cell models used were 
Figure 4.3: Cellular viability was assessed by the ATP luminescence assay (Mean±SD). 
Models assessed were normal wounded cells to which homeopathic remedy (H) prepared 
in distilled water (dH2O), 2.5% ethanol (2.5%), 5% ethanol (5%) and 10% ethanol (10%) were 
added. No significant difference was noted. n=3 
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normal, normal wounded, diabetic wounded and alcohol control (normal wounded cells 
with 5% EtOH added).  
 
The alcohol control group was added to ensure that the vehicle of the solution did not 
cause undue stress or prevent wound closure.  
 
Treatment with 5% EtOH by itself (no homeopathic remedies added) increased cellular 
migration into the cell-free area when compared to the dH2O control (Figure 4.5). This 
surprising effect was also seen in the preliminary experiment to determine the solution’s 
solvent (see section 4.1). Normal cells which were not wounded (Figure 4.6) did not show 
any differences following irradiation, homeopathic solution or combination treatment. The 
cell monolayer remained confluent over the 48 h period.  
 
Irradiating cells induced a dramatic increase in cellular migration in normal wounded 
groups (Figure 4.7). Homeopathic solution also increased wound closure, however to a 
lesser degree. Combination treatment had a greater effect on wound closure than either 
of these conditions alone.  
  
Figure 4.4: Cytotoxicity was assessed by the LDH membrane integrity assay (Mean±SD). 
Models assessed were normal wounded cells to which homeopathic solution (H) prepared in 
distilled water (dH2O), 2.5% ethanol (2.5%), 5% ethanol (5%) and 10% ethanol (10%) were 
added. Significant probability is shown as *P<0.05 and **P<0.01 compared to the control 
(dH2O) model. n=3 
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Migration of cells into the central scratch was much less in diabetic wounded models 
(Figure 4.8) compared to normal wounded models. Cells were present in the wound areas 
at 48 h but to a lesser extent than in normal wounded cells. Both laser and homeopathic 
solution improved cell migration in these models compared to the control, and a mild 
synergistic effect was seen with combination treatment. 
 
Irrespective of the model (diabetic or normal cells) irradiation and homeopathic solution 
both increased cell migration into the wound area to a greater extent than in controls. 
Cells maintained their characteristic shape and morphology, and there was minimal 
detachment from the culture flask and rounding of cells which are indicators of cell stress 
and cell death. 
 
 
 
 
Figure 4.5: Morphology of normal wounded cells treated with 5% ethanol (Alcohol 
Control) and distilled water (dH2O). Scale bars = 200 µm. n=3 
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Figure 4.6: Morphology of normal cell models. Treatment with laser irradiation, and or 
homeopathic solution did not change the morphology of WS1 human skin fibroblast cells. 
Cultures remained confluent over the 48 h period. Scale bars = 200 µm. n=3 
Figure 4.7: Morphology of normal wounded cell models. Laser treatment, homeopathic solution 
and a combination of the two accelerated cellular migration into the central scratch, with almost 
complete closure at 48 h in cells treated with both laser irradiation and homeopathic solution. 
Scale bars = 200 µm. n=3 
48 
 
4.2.2 Cellular viability 
Cellular viability was assessed by the Trypan Blue exclusion assay and by the ATP 
luminescence assay 48 h post-treatment. In the Trypan Blue exclusion assay (Figure 4.9) 
all models had a cell viability between 66% (Diabetic Wounded Homeopathy Laser) and 
81% (Normal Homeopathy Laser). In normal models the only significant difference was 
seen in irradiated normal cells which had decreased viability compared to the normal 
control (P<0.05). In the normal wounded models, the cells that received laser irradiation 
and homeopathic solution had decreased viability compared to the control cells (normal 
wounded) (P<0.01). A combination therapy also resulted in decreased viability in diabetic 
wounded cells (P<0.05). There were no statistically significant differences between group 
means as determined by one-way ANOVA. 
 
The ATP luminescence results are shown in Figure 4.10. ATP levels were decreased in 
wounded cells treated with 5% EtOH compared to control cells suggesting that the solvent 
of the solution had some degree of toxic effect. In normal models, laser treatment and 
homeopathic solution increased ATP levels in comparison to the control (P<0.05). The 
increase was greater in irradiated cells. However, combination treatment caused a 
decrease in ATP levels (P<0.05). In normal wounded models, laser treatment slightly 
Figure 4.8: Morphology of diabetic wounded cell models. Laser treatment, homeopathic solution 
and a combination of the two increased cellular migration into the central scratch over a period 
of 48 h. Scale bars = 200 µm. n=3 
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decreased viability (P<0.05) while homeopathic solution increased viability (P<0.001). 
Combination treatment decreased ATP levels (P<0.05). In diabetic wounded models the 
combination treatment group caused a significant increase in ATP levels compared to the 
control (P<0.05). 
 
One-way ANOVA revealed statistically significant differences between means in ATP 
luminescence. Homeopathic solution combined with irradiation levels were lower than 
irradiation by itself (Normal Laser vs Normal Homeopathy Laser, P<0.001). Wounding 
significantly decreased ATP levels in normal irradiated models (Normal Laser vs Normal 
Wounded Laser, P<0.001). In normal wounded models homeopathic solution increased 
ATP to a significantly greater extent than irradiation (Normal Wounded Laser vs Normal 
Wounded Homeopathy, P<0.001). Combination treatment also had decreased ATP 
compared to homeopathic solution (Normal Wounded Homeopathy Laser vs Normal 
Wounded Homeopathy, P<0.001). The alcohol control group had significantly lower levels 
of ATP compared to the homeopathic treated group (Normal Wounded (5%) vs Normal 
Wounded Homeopathy, P<0.001).  
 
4.2.3 Cytotoxicity 
Cytotoxicity was assessed by measuring the levels of LDH in culture medium (Figure 
4.11). LDH levels were significantly increased by treating cells with 5% EtOH compared 
to non-irradiated normal wounded controls (P<0.001). In normal models, homeopathic 
solution increased cytotoxicity (P<0.05) while combining homeopathic solution and 
irradiation resulted in decreased cytotoxicity (P<0.01). Irradiation of normal cells caused 
a slight decrease in LDH levels, but this did not reach statistical significance (P=0.072). 
In normal wounded models a similar trend is observed; homeopathic solution increased 
LDH levels (P<0.01) and a combination of irradiation and homeopathic solution 
decreased cytotoxicity (P<0.01). Once again irradiation by itself decreased cytotoxicity 
but this difference does not reach statistical significance (P=0.093). In diabetic wounded 
models the situation is reversed; irradiation significantly increased cytotoxicity (P<0.05), 
homeopathic solution decreased it (P<0.01) but similar to normal wounded models, 
combination treatment decreased cytotoxicity (P<0.01).  
 
One-way ANOVA showed statistically significant differences between means in LDH 
levels. In normal models, cells treated with a combination of laser and homeopathic 
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solution had decreased LDH levels compared to homeopathic solution alone (Normal 
Homeopathy Laser vs Normal Homeopathy, P<0.001). In normal wounded models, 
homeopathic solution caused significantly more LDH release than irradiation (Normal 
Wounded Homeopathy vs Normal Wounded Laser, P<0.001), combination treatment 
decreased LDH release compared to both irradiation (Normal Wounded Homeopathy 
Laser vs Normal Wounded Laser, P<0.05) and homeopathic solution (Normal Wounded 
Homeopathy Laser vs Normal Wounded Homeopathy, P<0.001) by themselves. In 
diabetic wounded groups combination treatment caused decreased LDH levels as 
compared to irradiation alone (Diabetic Wounded Homeopathy Laser vs Diabetic 
Wounded Laser, P<0.001).  
 
4.2.4 IL-6 and TNF-α ELISA 
Levels of the pro-inflammatory cytokines IL-6 and TNF-α in culture medium were 
established by using commercially available ELISA assay kits. The results of the IL-6 
ELISA are shown in Figure 4.12. Treating cells with 5% alcohol significantly increased  
IL-6 concentration compared to non-irradiated normal wounded cells (P<0.05). In normal 
models, homeopathic solution and combination treatment (homeopathic solution and 
laser irradiation) increased IL-6 concentration (P<0.05 and P<0.01, respectively). In 
normal wounded models, irradiation significantly decreased IL-6 concentration (P<0.05), 
while homeopathic solution by itself increased IL-6 (P<0.05). Combination treatment of 
normal wounded cells with homeopathic solution and laser irradiation significantly 
decreased IL-6 concentration (P<0.01). Irradiation of diabetic wounded models 
significantly decreased IL-6 concentration (P<0.001). 
 
One-way ANOVA revealed statistically significant differences in IL-6 concentration 
between groups. Wounding produced an increase in IL-6 (Normal Wounded vs Normal, 
P<0.001). Irradiation decreased IL-6 concentration in the combination treatment group 
compared to homeopathic solution by itself (Normal Homeopathy Laser vs Normal 
Homeopathy, P<0.001). In normal wounded models, homeopathic solution caused a 
significantly greater increase in IL-6 concentration compared to irradiation (Normal 
Wounded Homeopathy vs Normal Wounded Laser, P<0.001). Combination treatment 
models had decreased IL-6 concentration compared to the homeopathic group (Normal 
Wounded Homeopathy Laser vs Normal Wounded Homeopathy, P<0.001). In diabetic 
wounded models, homeopathic solution once again caused increased IL-6 concentration 
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compared to irradiation (Diabetic Wounded Homeopathy vs Diabetic Wounded Laser, 
P<0.001). Combination treatment caused greater IL-6 release than either condition by 
itself (Diabetic Wounded Homeopathy Laser vs Diabetic Wounded Laser, P<0.001; 
Diabetic Wounded Homeopathy Laser vs Diabetic Wounded Homeopathy, P<0.05).  
 
Results of the αα ELISA are shown in Figure 4.13. ELISA-TNF-α was decreased by 5% 
ethanol application (P<0.05). Homeopathic solution in normal cells and combined with 
irradiation decreased TNF-α concentration (P<0.05). In normal wounded models, 
homeopathic solution decreased TNF-α concentration as well (P<0.01). In diabetic 
wounded models, homeopathic solution combined with irradiation significantly increased 
TNF-α release into culture media (P<0.01).  
 
One-way ANOVA revealed statistically significant differences in TNF-α concentration 
between groups. Wounding cells decreased TNF-α release (Normal vs Normal Wounded, 
P<0.05). Combination treatment decreased TNF-α concentration compared to laser 
treatment alone (Normal Homeopathy Laser vs Normal Laser, P<0.05). Wounding cells 
also decreased TNF-α concentration in irradiated normal wounded models (Normal 
Wounded Laser vs Normal Laser, P<0.01). In normal wounded models irradiating cells 
caused greater TNF-α release compared to homeopathic solution alone (Normal 
Wounded Laser vs Normal Wounded Homeopathy, P<0.01).  
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Figure 4.9: Percentage cellular viability was assessed by the Trypan Blue exclusion assay. Models assessed included: normal (N), normal 
irradiated (NL), normal cells treated with homeopathic solution (NH), normal cells treated with homeopathic solution and irradiated (NHL), 
normal wounded (NW), normal wounded irradiated (NWL), normal wounded cells treated with homeopathic solution (NWH), normal 
wounded cells treated with homeopathic solution and irradiated (NWHL), diabetic wounded (DW), diabetic wounded irradiated (DWL), 
diabetic wounded cells treated with homeopathic solution (DWH), and diabetic wounded cells treated with homeopathic solution and 
irradiated (DWHL). An alcohol control model was included which consisted of normal wounded cells to which 5% EtOH was added 
((NW)5%). Significant probability is shown as *P<0.05 and **P<0.01 as compared to the non-irradiated controls (Mean±SD). n=3 
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Figure 4.10: Cellular viability was assessed by ATP luminescence. Models assessed included: normal (N), normal irradiated (NL), normal cells 
treated with homeopathic solution (NH), normal cells treated with homeopathic solution and irradiated (NHL), normal wounded (NW), normal 
wounded irradiated (NWL), normal wounded cells treated with homeopathic solution (NWH), normal wounded cells treated with homeopathic 
solution and irradiated (NWHL), diabetic wounded (DW), diabetic wounded irradiated (DWL), diabetic wounded cells treated with homeopathic 
solution (DWH), and diabetic wounded cells treated with homeopathic solution and irradiated (DWHL). An alcohol control model was included 
which consisted of normal wounded cells to which 5% EtOH was added ((NW)5%). Significant probability is shown as *P<0.05, **P<0.01 and 
***P<0.001 as compared to the non-irradiated controls (Mean±SD). n=3 
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Figure 4.11: Cytotoxicity was assessed by LDH membrane integrity. Models assessed included: normal (N), normal irradiated (NL), normal cells 
treated with homeopathic solution (NH), normal cells treated with homeopathic solution and irradiated (NHL), normal wounded (NW), normal 
wounded irradiated (NWL), normal wounded cells treated with homeopathic solution (NWH), normal wounded cells treated with homeopathic 
solution and irradiated (NWHL), diabetic wounded (DW), diabetic wounded irradiated (DWL), diabetic wounded cells treated with homeopathic 
solution  (DWH), and diabetic wounded cells treated with homeopathic solution and irradiated (DWHL). An alcohol control model was included 
which consisted of normal wounded cells to which 5% EtOH was added ((NW)5%). Significant probability is shown as *P<0.05, **P<0.01 and 
***P<0.001 as compared to the non-irradiated controls (Mean±SD). n=3 
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Figure 4.12: IL-6 cytokine levels were tested in culture medium. Models assessed included: normal (N), normal irradiated (NL), normal cells treated 
with homeopathic solution (NH), normal cells treated with homeopathic solution and irradiated (NHL), normal wounded (NW), normal wounded 
irradiated (NWL), normal wounded cells treated with homeopathic solution (NWH), normal wounded cells treated with homeopathic solution and 
irradiated (NWHL), diabetic wounded (DW), diabetic wounded irradiated (DWL), diabetic wounded cells treated with homeopathic solution (DWH), 
and diabetic wounded cells treated with homeopathic solution and irradiated (DWHL). An alcohol control model was included which consisted of 
normal wounded cells to which 5% EtOH was added ((NW)5%). Significant probability is shown as *P<0.05, **P<0.01 and ***P<0.001 as compared 
to non-irradiated control cells (Mean±SD). n=3 
56 
 
 
 
 
 
 
 
0,00
5,00
10,00
15,00
20,00
25,00
30,00
(NW) 5% N NL NH NHL NW NWL NWH NWHL DW DWL DWH DWHL
T
N
F
-α
c
o
n
c
e
n
tr
a
ti
o
n
 (
p
g
/m
L
)
* 
* 
* 
** 
** 
Figure 4.13: TNF-α cytokine levels were tested in culture medium. Models assessed included: normal (N), normal irradiated (NL), normal cells 
treated with homeopathic solution (NH), normal cells treated with homeopathic solution and irradiated (NHL), normal wounded (NW), normal 
wounded irradiated (NWL), normal wounded cells treated with homeopathic solution (NWH), normal wounded cells treated with homeopathic 
solution and irradiated (NWHL), diabetic wounded (DW), diabetic wounded irradiated (DWL), diabetic wounded cells treated with homeopathic 
solution (DWH), and diabetic wounded cells treated with homeopathic solution and irradiated (DWHL). An alcohol control model was included 
which consisted of normal wounded cells to which 5% EtOH was added ((NW)5%). Significant probability is shown as *P<0.05 and **P<0.01 as 
compared to non-irradiated control cells (Mean±SD). n=3 
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CHAPTER 5 
DISCUSSION AND CONCLUSION 
5.1 Overview 
The aim of this project was to determine whether exposing cells to PBM using laser light 
with a fluence of 5 J/cm2 and wavelength of 660 nm and treating them with a low potency 
homeopathic solution containing C. officinalis 3 cH, H. perforatum 3 cH and E. purpurea 
3 cH increased wound healing capacity in diabetic wounded cell models.  
 
Chronic wounds can occur in many disease conditions, including in DM, where non-
healing wounds are called DFUs. DFUs are a serious complication in DM as it may lead 
to lower limb amputations (Sohn et al., 2010). The aetiology of DFUs is multifactorial and 
may occur due to pathological changes such as ischaemia and neuropathy and altered 
immune responses present in DM (Tsourdi et al., 2013). DFUs are a burden on healthcare 
systems, and result in social problems such as disability and decreased quality of life 
(Ragnarson Tennvall & Apelqvist, 2004; Barg et al., 2017).  
 
Chronic wounds do not follow the regular sequence of wound healing which occurs in a 
limited timeframe and constitutes the phases of haemostasis, inflammation, proliferation 
and remodelling (Tsourdi et al., 2013). Chronic wounds are defined as barrier defects that 
fail to heal in three months (Nunan et al., 2014). They have several cellular and molecular 
changes which distinguishes them from acute wounds. Among other changes, they 
exhibit persistent inflammation, possibly infection, hyperproliferative epidermis but stalled 
re-epithelialisation, sub-optimal granulation tissue, fibroblast senescence, diminished 
angiogenesis and elevated MMPs (Nunan et al., 2014). 
 
PBM is a healing modality with established wound healing effects, including decreasing 
pain and inflammation and accelerating healing (Avci et al., 2013; Ramos et al., 2019). 
PBM is desirable as a therapeutic intervention because it has virtually no adverse effects, 
is non-invasive and is easy to administer (Avci et al., 2013). PBM refers to the use of red 
and NIR to stimulate healing. The main chromophores responsible for its beneficial effects 
are COX, which forms part of the mitochondrial electron transport chain, and calcium ion 
channels (Hamblin, 2017). The effects of light absorption by these chromophores are 
increased ATP, a short-lived burst of ROS, increased release of NO and changes in 
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calcium levels. Tertiary effects are varied and include activation of transcription factors 
which result in better cell survival, enhanced proliferation and migration and synthesis of 
new proteins (Hamblin, 2017). Its role in ROS modulation and inflammation seems to be 
a key player in stimulating healing. In normal cells, PBM increases ROS, however in 
oxidatively stressed cells or disease models it has the opposite effect, and it can decrease 
oxidative stress and up-regulate antioxidant defence mechanisms (Hamblin, 2017). 
Although its mechanism of action is not yet clearly understood, PBM has been shown to 
stimulate a variety of cellular responses and cause changes in various cell types. PBM 
acts on fibroblasts, where it increases the expression of genes involved in ECM 
production (Ayuk et al., 2014) and promotes the remodelling phase of wound healing by 
stimulating ECM synthesis and decreasing matrix breakdown (Ayuk et al., 2018).  
 
PBM has been the focus of much research for its applications in the medical field. Its 
efficacy has been investigated for medical conditions as disparate as dermatological 
conditions (Barolet, 2018), oral mucositis (Pinheiro et al., 2019) skeletal muscle recovery 
(Fisher et al., 2019) and chronic obstructive pulmonary disease (Miranda et al., 2019). It 
is favoured as an intervention to treat skin wounds, where it actively promotes healing, 
probably through its ability to stimulate various physiological processes such as 
inflammation resolution, neo-angiogenesis, proliferation of epithelial cells and fibroblasts, 
collagen synthesis and deposition, revascularisation and wound contraction (Andrade et 
al., 2014). In the context of DFUs, which are notoriously difficult to heal, it effectively 
stimulates healing as has been demonstrated in human and animal studies (Kaviani et 
al., 2011; Asghari et al., 2017; Yoshimura et al., 2016). 
 
Homeopathy is an alternative health modality that is based on the concept of ‘like cures 
like’ and has been proven to be effective in the treatment of a variety of health conditions 
such as upper respiratory tract infections and allergies (Bellavite et al., 2006) and 
childhood diarrhoea (Jacobs et al., 2003). It is regarded as safer than conventional 
pharmaceutical drugs (Kirby, 2002) and forms part of publicly funded healthcare systems 
in various countries such as Austria and France (Relton et al., 2017) and is especially 
popular in India where it is regarded as part of mainstream medicine (Shrivastava et al., 
2015). There is much controversy surrounding homeopathy, not least due to the concept 
of ‘ultramolecular dilutions’ which refers to the homeopathic practice of serially diluting 
the material starting substance, in some cases beyond Avogadro’s number (Fisher, 
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2012). Thus, dilutions beyond 23 X/D or 12 c/cH are very unlikely to contain a molecule 
of the starting substance (Fisher, 2012). Nevertheless, despite the fact that the 
mechanisms of action of homeopathy are still unclear, a number of meta-analyses and 
systematic reviews have been published which proves that homeopathy has curative 
effects which are not placebo (Linde et al., 1997; Mathie, 2003; Jonas et al., 2003).  
 
In this study, a combination of three low potency (i.e. highly concentrated) homeopathic 
remedies were tested as a therapeutic intervention. The three remedies were C. officinalis 
3 cH, H. perforatum 3 cH and E. purpurea 3 cH. Each of these substances, by themselves, 
have proven effective in accelerating wound healing in a herbal form (Parente et al., 2012; 
Samadi et al., 2010; Rezaie et al., 2013). There is very little published data on 
homeopathic medicines. Homeopathic literature, used in the practice of homeopathy, is 
based on empirical evidence gathered through homeopathic pathogenic trials, toxicology 
and clinical experience (Fisher, 2012). This literature indicates all three these remedies 
as useful in wound healing (Hering, 1997; Boericke, 1999; Sinha, 1981). In addition to 
this, Bresler et al. (2007) found encouraging cellular results in an in vitro experiment using 
homeopathic C. officinalis in a 3 cH potency, despite not finding statistically significant 
differences; H. perforatum in a 30 cH potency has also been shown to stimulate nerve 
regeneration in rats (Mohammadi et al., 2012).  
 
5.2 Effect of 5% Ethanol  
The 5% alcohol solvent used in this study caused accelerated wound healing as 
determined by qualitatively assessing wound closure via microscopy. In addition, cell 
viability measures (Trypan Blue and ATP luminescence) did not show any harmful effects 
of the 5% EtOH when compared to the dH2O group. When cytotoxicity was measured, 
however, there was a significant increase in LDH release showing that cells were more 
stressed when treated with 2.5%, 5% and 10% EtOH compared to dH2O. Taking all these 
results into consideration however, the 5% EtOH was chosen as a solvent due to its 
overall apparently beneficial effect. It would seem from the differences in the 
morphological changes in wounds and the LDH results that stressing cells does not 
necessarily equate with decreased migration abilities, and indeed 5% had the opposite 
effect when looking at the images – it augmented wound healing. 
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In later experiments, an alcohol control group was included to determine any possible 
harmful effects of the solvent. Wounded cells treated with medium with 5% EtOH added 
were compared to their control, which was wounded cells treated with normal medium 
without 5% EtOH. This is different to the control in the preliminary experiment where the 
same amount of dH2O was added to serve as a control.  
 
Cells treated with 5% EtOH had increased IL-6 expression compared to the NW control. 
They also had decreased ATP levels and increased LDH, indicating that the alcohol 
decreased viability and increased cytotoxicity. In contrast to this, the EtOH caused 
decreased TNF-α concentration, which is unexpected. Both TNF-α and IL-6 are pro-
inflammatory cytokines which are produced by fibroblasts (Brem et al., 2001) and are up-
regulated during the inflammatory phase of wound healing (Barrientos et al., 2008). IL-6 
is usually detectable immediately after injury, with peak levels reported soon after - within 
24 h (Gebhard et al., 2000), while TNF- α levels increase within 1-2 h after injury (Grellner 
et al., 2000) and reach maximum levels at 84 h after injury (Hirschl et al., 1996). 
 
It remains unclear whether an early increase or decrease in inflammatory markers is 
desirable. Healing is stimulated when levels of IL-6 and TNF-α (to a limited extent) are 
increased shortly after injury (Barrientos et al., 2008). However, some authors pronounce 
that inflammation is a double-edged sword and could be the major cause of scarring 
(Martin & Nunan, 2015). The timeline of an increase in inflammation is likely a crucial 
consideration – early inflammation is necessary for healing while persistent inflammation 
is a hallmark of chronic wounds (Loots et al., 1998). This study investigated changes 48 
h after injury and so falls within this early period. It is uncertain to what extent this model 
is indicative of the chronic wounds of DM, DFUs, however as those tissues have been 
exposed to an inflammatory milieu for greater than 3 months (Nunan et al., 2014). 
 
What was observed was increased wound closure due to alcohol exposure – an example 
of a stress condition. It is likely that sub-lethal levels of alcohol may cause cellular stress 
which could stimulate healing. Singh et al. (2016) investigated the effects of sterile 
inflammation, which could also be seen as a stress condition, induced by endotoxin 
application in rat wounds. They found that re-epithelialisation and wound closure were 
significantly increased in endotoxin-treated wounds compared to wounds treated with 
inflammatory mediator inhibitors. This response mirrors the response found in this study 
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when adding different concentrations of low concentration alcohol to culture medium. In 
addition, cell types react differently to alcohol. Alcohol concentrations as low as 1.5% are 
cytotoxic to human hepatoma cells (Fukaya et al.,1997), while others found indications of 
damage only at a concentration of 8% ethanol after 3 h exposure in an experiment using 
4-12% ethanol in rat gastric epithelial cells (Hiraishi et al., 1999), and that the amount of 
damage was dependent on the concentration and ethanol exposure time.  
 
5.3 Normal Wounded Models 
5.3.1 Effect of homeopathic solution in normal wounded cells 
No other studies were found which used the specific combination of homeopathic 
remedies used in this study, limiting comparison to the literature. The homeopathic 
solution was effective in improving cellular migration when the morphological data is 
considered – more cells were present in the wounded area at 48 h in homeopathic groups. 
This effect may be attributed to the 5% alcohol in the solution, as previously discussed. 
This is supported by the findings of others; Fronza et al. (2009) found that treating cells 
with C. officinalis herbal extract increased cellular migration using the scratch assay. 
Hostanska et al. (2012) also used a combination homeopathic complex for investigating 
wound healing and found that a solution containing C. officinalis 4x and H. perforatum 4x 
among other remedies increased cellular migration without affecting proliferation. Bresler 
et al. (2007) found considerable migration of fibroblasts into the central scratch after 
treatment with C. officinalis 3 cH.  
 
Homeopathic solution increased cellular viability as indicated by ATP luminescence; a 
result also found by Bresler et al. (2007) using C. officinalis 3 cH. Cytotoxicity was 
increased as indicated by increased LDH levels. This effect might be due to the effect of 
the 5% alcohol solvent, however, Bresler et al. (2007) found the opposite effect with 3 cH 
C. officinalis also made up in 5% EtOH. There was a slight methodological difference in 
the study of Bresler et al. (2007) in that they added 10 µL of homeopathic solution to 2 
mL of culture medium on day 1 and day 2 of the experiment, and the LDH assay was only 
performed at day 3; while in this study 30 µL of solution (containing H. perforatum and E. 
purpurea which Bresler et al. (2007) didn’t include) was added 30 min after wounding in 
a single dose, and the LDH assay was performed at day 2.  
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The homeopathic solution increased IL-6 concentration, indicating a pro-inflammatory 
effect, however this may be due to the effect of the alcohol solvent. The solution 
decreased TNF-α concentration, which could indicate suppression of inflammation. 
Another possibility is that the 48 h timepoint used in this study may just be too early to 
detect TNF-α levels as they typically peak much later than IL-6 concentration (Hirschl et 
al., 1996). This study might have missed an ‘early peak’ of TNF-α as it has been reported 
that levels increase in the first hours after injury, and then reappear only after days 
(Grellner, 2002). For this reason, IL-6 results might be a more reliable indicator of 
inflammation in this study.  
 
5.3.2 Effect of PBM in normal wounded cells 
To generate a model of PBM, cells were exposed to 5 J/cm2 laser light at 660 nm. 
Irradiation was very effective in accelerating wound healing as indicated by morphological 
data. Qualitatively assessing the images reveal that more cells migrated into the wounded 
zone of irradiated cells than control cells and more than in cells treated with homeopathic 
solution. Others have also found an increase in cellular migration following PBM in wound 
healing studies (Tricarico et al., 2018; Bresler et al., 2007).  
 
Cellular viability as indicated by ATP luminescence was decreased by laser treatment. 
The findings of Bresler et al. (2007) contradict this – they found irradiation increased ATP 
levels, although this change was not statistically significant. Laser treatment was not toxic 
to cells as LDH levels remained unchanged compared to controls. This contradicts what 
Bresler et al. (2007) found – in that study fibroblasts that were irradiated had the highest 
LDH levels, however the increase did not reach statistical significance. 
 
IL-6 was decreased in irradiated normal wounded cells, displaying an anti-inflammatory 
response, which corroborates the established anti-inflammatory effects of PBM (Lopes-
Martins et al., 2005). TNF-α levels did not change significantly. Lima et al. (2014) found 
that PBM decreased IL-6 concentration 6 h after a surgery intervention in rats, however 
they did not find a change in TNF-α levels at this timepoint, which supports this study’s 
findings at 48 h.  
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5.3.3 Effect of homeopathic solution combined with PBM in normal wounded cells 
Combination treatment in this study involved irradiating cells that had the homeopathic 
complex remedy added to culture medium. This treatment was successful in accelerating 
wound closure as determined by morphological data. In fact, the change was more than 
in either homeopathically or laser treated cells by themselves, pointing to a synergistic 
effect. Bresler et al. (2007) found that first irradiating cells, then treating them with C. 
officinalis 3 cH induced haptotaxis at the wound margin, but that minimal migration took 
place when cells were first treated homeopathically, then irradiated. In this case the cells 
did not seem to be adversely affected by the order in which the remedy was added, and 
in fact the combination therapy seems to be very favourable if one considers the 
morphological data, which contradicts Bresler et al.’s (2007) findings.  
 
However, the situation is different if one considers the viability data. Combination therapy 
decreased cellular viability as indicated by Trypan Blue and ATP results, supporting the 
unfavourable effect of irradiation and homeopathic C. officinalis found by Bresler et al. 
(2007). Combination treatment decreased LDH levels indicating that it decreased toxicity, 
while Bresler et al. (2007) found that C. officinalis treatment followed by PBM increased 
cytotoxicity.  
 
The LDH data is in line with what was observed qualitatively in the images, and further 
supports the notion that combination therapy decreases membrane damage in normal 
wounded models. Combination treatment increased IL-6 concentration, pointing to a pro-
inflammatory effect. Once again this is probably due to the effect of the 5% EtOH solvent 
of the remedy. Indeed, the effect of irradiation ameliorated IL-6 release in the combination 
group when it is compared to the homeopathic solution-only group. TNF-α levels were 
unchanged with this treatment protocol.  
 
5.4 Diabetic Wounded Models 
5.4.1 Effect of homeopathic remedy complex in diabetic wounded cells 
Diabetic models were consistently exposed to high-glucose medium. There was a marked 
difference in wound morphology at 48 h in diabetic wounded cells compared to normal 
wounded cells, which confirms what is known – hyperglycaemia delays wound healing 
(Markuson et al., 2009), including by inhibiting fibroblast migration (Xuan et al., 2014).  
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Treatment with the homeopathic complex remedy improved fibroblast migration. This is 
supported by other literature, in the case of C. officinalis (Fronza et al., 2009); however, 
that study was done on a non-diabetic model, and they used a herbal extract of C. 
officinalis. The wound healing effects of C. officinalis in the context of DM have been 
proven, however in a human trial (Carvalho et al., 2016).  
 
Cellular viability as indicated by Trypan Blue and ATP results was not affected by 
homeopathic remedy treatment, a favourable outcome, and in line with what Bresler et 
al. (2007) found, however they used non-diabetic cells. In addition, homeopathic solution 
caused decreased cytotoxicity in diabetic wounded cells as indicated by LDH levels. 
These results are somewhat different to the findings in the normal and normal wounded 
groups treated with the homeopathic remedy, where the remedy caused increased 
cytotoxicity.  
 
Both pro-inflammatory cytokines remained unchanged with homeopathic solution. 
However, IL-6 concentration of homeopathically treated cells were significantly higher 
when compared to irradiated models, which is also the trend in the normal and normal 
wounded models and may possibly be ascribed to the effect of the alcohol solvent as 
discussed above.  
 
5.4.2 Effect of PBM in diabetic wounded cells 
PBM improved cellular migration slightly in diabetic wounded models. This finding is 
supported by Byrnes et al. (2004) who used 4 J/cm2, 623 nm laser light in wounded 
diabetic rats, and by Houreld and Abrahamse (2007) in an in vitro study using diabetic 
wounded cells and the same laser parameters as in this study. They found that PBM had 
a significant effect in improving wound healing as assessed by cellular morphology 
studies. Kaviani et al. (2011) also found that PBM treatment accelerated wound healing 
in patients with DFUs.  
 
Diabetic wounded irradiated cells had unchanged cellular viability measures. Others have 
found that PBM increases cellular viability, so this study’s results contradict those finding 
(Esmaeelinejad et al. 2014; Jere et al., 2018). Cytotoxicity was increased by irradiation 
as indicated by elevated LDH levels. This is a surprising finding and contradicts what was 
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found in the normal models and normal wounded models. Others have found that PBM 
is not cytotoxic in diabetic wounded cells (Houreld & Abrahamse, 2007). 
 
PBM was found to decrease IL-6 concentration in this model. This supports the 
established anti-inflammatory effect of PBM (Hamblin, 2017), and Yoshimura et al. (2016) 
have demonstrated that PBM (5.7 J/cm2, 842 nm) significantly decreases inflammatory 
cell infiltrates in adipose tissue of hyperglycaemic mice. TNF-α levels remained 
unchanged, as with most of the interventions in this study. 
 
5.4.3 Effect of homeopathic remedy complex combined with PBM in diabetic 
wounded cells 
Combination therapy increased cellular migration in diabetic wounded cells. Furthermore, 
this effect was greater than either condition alone, pointing to a synergistic effect. This 
finding supports the results of Carvalho et al. (2016) who found that combining C. 
officinalis oil and PBM (4 J/cm2, 658 nm) accelerated healing of DFUs in study 
participants. This effect was also found in normal wounded cells.  
 
Trypan Blue levels show decreased viability; however, ATP levels were increased. These 
results show contradictory effects with regards to cellular viability. However, there were 
large error margins with the Trypan Blue results, and much smaller ones with ATP results, 
thus the ATP results might be more reliable. Another consideration is that, despite the 
fact that both these assays are used as cellular viability indices, they work on different 
mechanisms. ATP levels might be increased in cells that are more metabolically active or 
decreased in cells that are less metabolically active but still viable. The literature shows 
that PBM increases cellular viability in diabetic models (Esmaeelinejad et al., 2014; Jere 
et al., 2018) and that homeopathic C. officinalis combined with PBM increased ATP levels 
in non-diabetic fibroblasts (Bresler et al., 2007). There is a lack of studies in DM models 
with the use of the specific combination of C. officinalis, H. perforatum and E. purpurea 
as well as combined with PBM.  
 
Combination therapy decreased LDH levels, which was also the effect observed in normal 
and normal wounded models and is an encouraging result. There was no change in IL-6 
concentration with combination treatment compared to controls, however IL-6 
concentration were increased to a greater extent in the combination group when 
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compared to the homeopathic and PBM single treatment protocols. This might be an 
indication of a greater degree of cellular damage inflicted by these therapies in 
combination. Houreld and Abrahamse (2007) found that irradiating cells with either 
5 J/cm2 or 16 J/cm2 increased apoptosis in diabetic and normal models when compared 
to non-irradiated controls, which indicated that some degree of damage is inflicted by 
irradiation at least.  
 
The results of the alcohol control group showed increased IL-6 release compared to 
controls, which could be an explanation for the increased IL-6 seen in the combination 
therapy group. There was an increase in TNF-α. This contradicts what Lima et al. (2014) 
found, as mentioned above which was unchanged TNF-α levels 6 h after surgery. 
However, that study evaluated TNF-α levels at 48 h and was performed on diabetic cells.  
 
5.5 Conclusion and Future Recommendations 
This study revealed a number of interesting findings related to the combined application 
of PBM and a 3 cH homeopathic solution for the development of potential treatment of 
states associated with diabetic injury, such as DFUs.   
 
The wound-healing effects of PBM in the context of DM were confirmed in this study. 
Irradiating cells greatly enhanced cellular migration into the wound area in normal 
wounded cells and moderately in diabetic wounded cells, but still more than control cells. 
However, despite this PBM was found to increase cytotoxicity. It was found to be anti-
inflammatory based on IL-6 results. 
 
The alcohol model was noted to have had an independent effect on various cellular 
parameters. As such, homeopathically-prepared C. officinalis, H. perforatum and E. 
purpurea 3 cH  improved cellular migration in all models, although to a lesser extent in 
normal wounded models than PBM. Additional investigation is required as to the role of 
alcohol with respect to cellular migration. Homeopathic solution decreased cytotoxicity 
but was not anti-inflammatory based on cytokine responses.  
 
Combination therapy involving homeopathic solution followed by irradiation increased 
wound healing as evidenced by increased cellular migration. In addition, a synergistic 
effect was found in both diabetic wounded and normal wounded models in combining the 
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two therapies. Combination therapy also decreased cytotoxicity and increased cellular 
viability as indicated by ATP production.  
 
The model used in this study proved its usefulness as a mimic of wounds in DM due to 
the dysfunctional healing demonstrated by slowed fibroblast migration in diabetic 
wounded models. In addition, IL-6 release was significantly increased in normal wounded 
models compared to non-wounded models (data not shown), confirming a pro-
inflammatory environment induced by the scratch assay, and making it useful for serving 
as an example of real-life wounds. The IL-6 and TNF-α results generated in this study 
indicate the complicated nature of cytokine responses. TNF-α was not altered for most 
conditions and further investigation to determine effects on cytokine release at various 
timepoints after wounding is recommended to establish effects over a period of time. It is 
uncertain whether this model, which investigated effects in wounds over 48 h would be 
representative of the uniquely deranged cytokine environment present in DFUs.  
 
The alcohol model had an independent effect on various cellular parameters. It would be 
advisable to prepare homeopathic remedies in distilled water in future in vitro studies.  
 
In conclusion, the combination of PBM and a homeopathic complex containing 3 cH C. 
officinalis, H. perforatum and E. purpurea improved wound healing in an in vitro model of 
DFUs. More research including further investigation of the role of alcohol preparations 
and their comparison to distilled water preparations is necessary to confirm these results 
and to establish the mechanisms of action related to the beneficial effects of the combined 
treatment, other potencies of the remedies used as well as mother tinctures. This may, in 
turn, lead to use of optimal treatment combinations for use in in vivo models. 
  
68 
 
REFERENCES 
 
Acosta, J.B., Garcia del Barco, D., Cibrian Vera, D., Savigne, W., Lopez‐Saura, P., 
Guillen Nieto, G. and Schultz, G.S. (2008) The pro‐inflammatory environment in 
recalcitrant diabetic foot wounds. International Wound Journal, 5(4):530-539. 
 
AlGhamdi, K.M., Kumar, A. and Moussa, N.A. (2012) Low-level laser therapy: a useful 
technique for enhancing the proliferation of various cultured cells. Lasers in Medical 
Science, 27(1):237-249. doi: 10.1007/s10103-011-0885-2 
 
Al-Watban, F.A. and Andres, B.L. (2000) Laser photons and pharmacological treatments 
in wound healing. Laser Therapy, 12(1):3-11. 
 
Amin, N. and Doupis, J. (2016) Diabetic foot disease: from the evaluation of the “foot at 
risk” to the novel diabetic ulcer treatment modalities. World Journal of Diabetes, 7(7):153-
164. doi: 10.4239/wjd.v7.i7.153 
 
Andrade, F.D., Clark, R.M. and Ferreira, M.L. (2014) Effects of low-level laser therapy on 
wound healing. Revista do Colégio Brasileiro de Cirurgiões, 41(2):129-133. doi: 
10.1590/S0100-69912014000200010 
 
Ao, J., Wood, J.P., Chidlow, G., Gillies, M.C. and Casson, R.J. (2018) Retinal pigment 
epithelium in the pathogenesis of age‐related macular degeneration and 
photobiomodulation as a potential therapy? Clinical & Experimental 
Ophthalmology, 46(6):670-686. doi: 10.1111/ceo.13121 
 
Arora, D., Rani, A. and Sharma, A. (2013) A review on phytochemistry and 
ethnopharmacological aspects of genus Calendula. Pharmacognosy 
Reviews, 7(14):179-187. doi: 10.4103/0973-7847.120520 
 
Asghari, M., Kanonisabet, A., Safakhah, M., Azimzadeh, Z., Mostafavinia, A., Taheri, S., 
Amini, A., Ghorishi, S.K., JalaliFiroozkohi, R., Bayat, S. and Bayat, M. (2017) The effect 
of combined photobiomodulation and metformin on open skin wound healing in a non-
69 
 
genetic model of type II diabetes. Journal of Photochemistry and Photobiology B: 
Biology, 169:63-69. doi: 10.1016/j.jphotobiol.2017.03.002 
 
Avci, P., Gupta, A., Sadasivam, M., Vecchio, D., Pam, Z., Pam, N. and Hamblin, M.R. 
(2013) Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. 
Seminars in Cutaneous Medicine and Surgery, 32(1):41-52. 
 
Ayuk, S.M. (2012) Collagen production in wounded fibroblasts in response to low intensity 
laser irradiation (Master’s thesis). Doornfontein, institutional database. Johannesburg: 
University of Johannesburg. Available from: 
https://ujcontent.uj.ac.za/vital/access/manager/Repository/uj:10683?site_name=GlobalV
iew. [Accessed 28 September 2019] 
 
Ayuk, S.M., Houreld, N.N. and Abrahamse, H. (2014) Laser irradiation alters the 
expression profile of genes involved in the extracellular matrix in vitro. International 
Journal of Photoenergy (604518):1-17. doi: 10.1155/2014/604518 
 
Ayuk, S.M., Abrahamse, H. and Houreld, N.N. (2016) The role of photobiomodulation on 
gene expression of cell adhesion molecules in diabetic wounded fibroblasts in 
vitro. Journal of Photochemistry and Photobiology B: Biology, 161:368-374. doi: 
10.1016/j.jphotobiol.2016.05.027 
 
Ayuk, S.M., Abrahamse, H. and Houreld, N.N. (2018) Photobiomodulation alters matrix 
protein activity in stressed fibroblast cells in vitro. Journal of Biophotonics, 11(3), 
p.e201700127. doi: 10.1002/jbio.201700127 
 
Bainbridge, P. (2013) Wound healing and the role of fibroblasts. Journal of Wound 
Care, 22(8):407-411. doi:10.12968/jowc.2013.22.8.407 
 
Baltzis, D., Eleftheriadou, I. and Veves, A. (2014) Pathogenesis and treatment of impaired 
wound healing in diabetes mellitus: new insights. Advances in Therapy, 31(8):817-836. 
doi: 10.1007/s12325-014-0140 
 
70 
 
Barg, F.K., Cronholm, P.F., Easley, E.E., Davis, T., Hampton, M., Malay, D.S., Donohue, 
C., Song, J., Thom, S.R. and Margolis, D.J. (2017) A qualitative study of the experience 
of lower extremity wounds and amputations among people with diabetes in 
Philadelphia. Wound Repair and Regeneration, 25(5):864-870. doi: 10.1111/wrr.12593 
 
Barnes, J., Anderson, L.A. and Phillipson, J.D. (2001) St John's wort (Hypericum 
perforatum L.): a review of its chemistry, pharmacology and clinical properties. Journal of 
Pharmacy and Pharmacology, 53(5):583-600. 
 
Barolet, D. (2008) Light-emitting diodes (LEDs) in dermatology. Seminars in Cutaneous 
Medicine and Surgery, 27(4):227-238. doi: 10.1016/j.sder.2008.08.003 
 
Barolet, D. (2018) Photobiomodulation in dermatology: harnessing light from visible to 
near infrared. Medical Research Archives, 6(1). doi: 10.18103/mra.v6i1.1610 
 
Barrientos, S., Stojadinovic, O., Golinko, M.S., Brem, H. and Tomic‐Canic, M. (2008) 
Growth factors and cytokines in wound healing. Wound Repair and 
Regeneration, 16(5):585-601. doi: 10.1111/j.1524-475X.2008.00410.x 
 
Bellavite, P., Ortolani, R., Pontarollo, F., Piasere, V., Benato, G. and Conforti, A. (2006) 
Immunology and homeopathy. 4. Clinical studies - Part 1. Evidence-Based 
Complementary and Alternative Medicine, 3:293-301. doi: 
http://dx.doi.org/10.1093/ecam/nel045 
 
Bertram, M.Y., Jaswal, A.V., Van Wyk, V.P., Levitt, N.S. and Hofman, K.J. (2013) The 
non-fatal disease burden caused by type 2 diabetes in South Africa, 2009. Global Health 
Action, 6(1):19244. doi: 10.3402/gha.v6i0.19244 
 
Boericke, W. (1999). A pocket manual of homeopathic materia medica and repertory. 
Reprint edition. New Delhi: B Jain Publishers 
 
Boulton, A.J. (2013) The pathway to foot ulceration in diabetes. Medical 
Clinics, 97(5):775-790. doi: 10.1016/j.mcna.2013.03.007 
71 
 
Boulton, A.J., Vileikyte, L., Ragnarson-Tennvall, G. and Apelqvist, J. (2005) The global 
burden of diabetic foot disease. The Lancet, 366(9498):1719-1724. doi: 10.1016/S0140-
6736(05)67698-2  
 
Braun, L. and Cohen, M. (2010) Herbs & Natural supplements: an evidence-based guide. 
3rd edition. 2010. Chatswood: Elsevier Australia 
 
Brem, H.A., Young, J., Tomic-Canic, M., Isaacs, C. and Ehrlich, H.P. (2001) Clinical 
efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of 
diabetic foot ulcers. Surgical Technology International, 11: 23-31.  
 
Bresler, A., Hawkins, D., Razlog, R. and Abrahamse, H. (2007) Effect of low level laser 
therapy and Calendula officinalis 3 CH on wound healing in human skin fibroblasts. 
American Journal of Homeopathic Medicine, 100(2):110-119.  
 
Byrnes, K.R., Barna, L., Chenault, V.M., Waynant, R.W., Ilev, I.K., Longo, L., Miracco, C., 
Johnson, B. and Anders, J.J. (2004) Photobiomodulation improves cutaneous wound 
healing in an animal model of type II diabetes. Photomedicine and Laser 
Therapy, 22(4):281-290. doi: 10.1089/pho.2004.22.281 
 
Cahn, A., Livshits, L., Srulevich, A., Raz, I., Yedgar, S. and Barshtein, G. (2016) Diabetic 
foot disease is associated with reduced erythrocyte deformability. International Wound 
Journal, 13(4):500-504. doi: 10.1111/iwj.12466 
 
Carvalho, A.F.M.D., Feitosa, M.C.P., Coelho, N.P.M.D.F., Rebêlo, V.C.N., Castro, J.G.D., 
Sousa, P.R.G.D., Feitosa, V.C. and Arisawa, E.A.L.S. (2016) Low-level laser therapy and 
Calendula officinalis in repairing diabetic foot ulcers. Revista da Escola de Enfermagem 
da USP, 50(4):628-634. doi:  http://dx.doi.org/10.1590/S0080-623420160000500013 
 
Chao, C.Y. and Cheing, G.L. (2009) Microvascular dysfunction in diabetic foot disease 
and ulceration. Diabetes/metabolism Research and Reviews, 25(7):604-614. 
doi:10.1002/dmrr.1004 
 
72 
 
Cho, N., Shaw, J.E., Karuranga, S., Huang, Y., da Rocha Fernandes, J.D., Ohlrogge, 
A.W. and Malanda, B. (2018) IDF Diabetes Atlas: Global estimates of diabetes 
prevalence for 2017 and projections for 2045. Diabetes Research and Clinical 
Practice, 138:271-281. doi: 10.1016/j.diabres.2018.02.023  
 
Jacobs, J., Jonas, W.B., Jimenez-Perez, M. and Crothers, D. (2003) Homeopathy for 
childhood diarrhea: combined results and metaanalysis from three randomized, 
controlled clinical trials. The Pediatric Infectious Disease Journal, 22(3):229-234. 
 
De Almeida, P., Lopes‐Martins, R.Á., Tomazoni, S.S., Silva Jr, J.A., Carvalho, P.D., 
Bjordal, J.M. and Leal Junior, E.C. (2011) Low‐level laser therapy improves skeletal 
muscle performance, decreases skeletal muscle damage and modulates mRNA 
expression of COX‐1 and COX‐2 in a dose‐dependent manner. Photochemistry and 
Photobiology, 87(5):1159-1163. doi: 10.1111/j.1751-1097.2011.00968.x 
 
De Freitas, L.F. and Hamblin, M.R. (2016) Proposed mechanisms of photobiomodulation 
or low-level light therapy. IEEE Journal of Selected Topics in Quantum 
Electronics, 22(3):348-364. doi: 10.1109/JSTQE.2016.2561201 
 
Diegelmann, R.F. and Evans, M.C. (2004) Wound healing: an overview of acute, fibrotic 
and delayed healing. Frontiers in Bioscience, 9(1):283-289. 
 
Emanuelli, T., Burgeiro, A. and Carvalho, E., (2016) Effects of insulin on the skin: possible 
healing benefits for diabetic foot ulcers. Archives of Dermatological 
Research, 308(10):677-694. doi: 10.1007/s00403-016-1686-z 
 
Esmaeelinejad, M., Bayat, M., Darbandi, H., Bayat, M. and Mosaffa, N. (2014) The effects 
of low-level laser irradiation on cellular viability and proliferation of human skin fibroblasts 
cultured in high glucose mediums. Lasers in Medical Science, 29(1):121-129. doi: 
10.1007/s10103-013-1289-2 
 
Fisher, P. (2012) What is homeopathy? An introduction. Frontiers in Bioscience (Elite Ed), 
4:1669-1682. 
73 
 
Fisher, S.R., Rigby, J.H., Mettler, J.A. and McCurdy, K.W. (2019) The Effectiveness of 
Photobiomodulation Therapy Versus Cryotherapy for Skeletal Muscle Recovery: A 
Critically Appraised Topic. Journal of Sport Rehabilitation, 28:526-531. doi: 
10.1123/jsr.2017-0359 
 
Fagrell, B., Jörneskog, G. and Intaglietta, M. (1999) Disturbed microvascular reactivity 
and shunting-a major cause for diabetic complications. Vascular Medicine, 4(3):125-127. 
 
Felice, F., Zambito, Y., Belardinelli, E., Fabiano, A., Santoni, T. and Di Stefano, R. (2015) 
Effect of different chitosan derivatives on in vitro scratch wound assay: a comparative 
study. International Journal of Biological Macromolecules, 76:236-241. doi: 
10.1016/j.ijbiomac.2015.02.041 
 
Flavell, S.J., Hou, T.Z., Lax, S., Filer, A.D., Salmon, M. and Buckley, C.D. (2008) 
Fibroblasts as novel therapeutic targets in chronic inflammation. British Journal of 
Pharmacology, 153(S1):S241-S246. doi: 10.1038/sj.bjp.0707487 
 
Fronza, M., Heinzmann, B., Hamburger, M., Laufer, S. and Merfort, I. (2009) 
Determination of the wound healing effect of Calendula extracts using the scratch assay 
with 3T3 fibroblasts. Journal of Ethnopharmacology, 126(3):463-467. 
 
Fukaya, K., Miyazaki, M., Pu, H., Katayama, B., Inoue, Y., Ohashi, R., Nakamura, C. and 
Namba, M. (1997). Pyruvate alleviates toxic effects of ethanol on cells in culture. Archives 
of toxicology, 71(10):651-654. 
 
Game, F.L., Apelqvist, J., Attinger, C.E.A., Hartemann, A., Hinchliffe, R.J., Löndahl, M., 
Price, P.E., Jeffcoate, W.J. and International Working Group on the Diabetic Foot 
(IWGDF) (2016) Effectiveness of interventions to enhance healing of chronic ulcers of the 
foot in diabetes: a systematic review. Diabetes/Metabolism Research and 
Reviews, 32:154-168. doi: 10.1002/dmrr.2707 
 
Gebhard, F., Pfetsch, H., Steinbach, G., Strecker, W., Kinzl, L. and Brückner, U.B., (2000) 
Is interleukin 6 an early marker of injury severity following major trauma in 
humans?. Archives of Surgery, 135(3):291-295. doi: 10.1001/archsurg.135.3.291 
74 
 
German Homoeopathic Pharmacopoeia Volume 1 (GHP). (2012). Stuttgart: MedPharm 
Scientific Publishers.  
 
Grellner, W., Georg, T. and Wilske, J. (2000) Quantitative analysis of proinflammatory 
cytokines (IL-1β, IL-6, TNF-α) in human skin wounds. Forensic science 
international, 113(1-3):251-264. doi: 10.1016/S0379-0738(00)00218-8 
 
Grellner, W. (2002) Time-dependent immunohistochemical detection of proinflammatory 
cytokines (IL-1β, IL-6, TNF-α) in human skin wounds. Forensic Science 
International, 130(2-3):90-96. 
 
Groenendaal, W., Von Basum, G., Schmidt, K.A., Hilbers, P.A. and van Riel, N.A. (2010) 
Quantifying the composition of human skin for glucose sensor development. Journal of 
Diabetes Science and Technology, 4(5):1032-1040.  
 
Hall, V., Thomsen, R.W., Henriksen, O. and Lohse, N. (2011) Diabetes in Sub Saharan 
Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC 
Public Health, 11(1):564. doi: 10.1186/1471-2458-11-564 
 
Hamblin, M.R. (2017) Mechanisms and applications of the anti-inflammatory effects of 
photobiomodulation. AIMS Biophysics, 4(3):337–361. doi:10.3934/biophy.2017.3.337  
 
Han, G. and Ceilley, R. (2017) Chronic wound healing: a review of current management 
and treatments. Advances in Therapy, 34(3):599-610. doi: 10.1007/s12325-017-0478-y 
 
Han, M.C., Durmis A.S., Sağliyan, A., Günay, C., Özkaraca, M., Kandemir, F.M., Comakli, 
S. and Öztopalan, D.F. (2017) Effects of Nigella sativa and Hypericum perforatum on 
wound healing. Turkish Journal of Veterinary and Animal Sciences, 41:99-105. 
 
Hansen, J.T.  (2017). Netter's Clinical Anatomy E-Book. Philadelphia: Elsevier Health 
Sciences. 
 
Hering, C. (1997) The guiding symptoms of our materia medica. Reprint edition. New 
Delhi: B Jain Publishers 
75 
 
Hernández‐Caldera, A., Vernal, R., Paredes, R., Veloso‐Matta, P., Astorga, J. and 
Hernández, M. (2018) Human periodontal ligament fibroblasts synthesize C‐reactive 
protein and Th‐related cytokines in response to interleukin (IL)‐6 trans‐
signalling. International Endodontic Journal, 51(6):632-640. doi: 10.1111/iej.12872 
 
Hiraishi, H., Shimada, T., Ivey, K.J. and Terano, A. (1999). Role of antioxidant defenses 
against ethanol-induced damage in cultured rat gastric epithelial cells. Journal of 
pharmacology and Experimental Therapeutics, 289(1):103-109. 
 
Hirschl, M.M.; Gwechenberger, M.; Binder, T.; Binder, M.; Graf, S.; Stefenelli, T.; 
Rauscha, F.; Laggner, A.N. and Sochor, H. (1996) Assessment of myocardial injury by 
serum tumour necrosis factor alpha measurements in acute myocardial infarction. 
European Heart Journal, 17(12):1852-1859. doi: 
10.1093/oxfordjournals.eurheartj.a014803 
 
Hoffstad, O., Mitra, N., Walsh, J. and Margolis, D.J. (2015) Diabetes, lower-extremity 
amputation, and death. Diabetes Care, 38(10):1852-1857. doi: 10.2337/dc15-0536 
 
Hopkins, J.T., McLoda, T.A., Seegmiller, J.G. and Baxter, G.D. (2004) Low-level laser 
therapy facilitates superficial wound healing in humans: a triple-blind, sham-controlled 
study. Journal of Athletic Training, 39(3):223-229.  
 
Hostanska, K., Rostock, M., Melzer, J., Baumgartner, S. and Saller, R. (2012) A 
homeopathic remedy from arnica, marigold, St. John’s wort and comfrey accelerates in 
vitro wound scratch closure of NIH 3T3 fibroblasts. BMC Complementary and Alternative 
Medicine, 12(1):100. doi: 10.1186/1472-6882-12-100 
 
Houreld, N. and Abrahamse, H. (2007) In vitro exposure of wounded diabetic fibroblast 
cells to a helium-neon laser at 5 and 16 J/cm2. Photomedicine and Laser 
Surgery, 25(2):78-84. doi: 10.1089/pho.2006.990 
 
76 
 
Houreld, N.N., Ayuk, S.M. and Abrahamse, H. (2018) Cell adhesion molecules are 
mediated by photobiomodulation at 660 nm in diabetic wounded fibroblast 
cells. Cells, 7(4):30. doi: 10.3390/cells7040030 
 
Jere, S.W., Houreld, N.N. and Abrahamse, H. (2018) Photobiomodulation at 660 nm 
stimulates proliferation and migration of diabetic wounded cells via the expression of 
epidermal growth factor and the JAK/STAT pathway. Journal of Photochemistry and 
Photobiology B: Biology, 179:74-83. doi: 10.1016/j.jphotobiol.2017.12.026 
 
Jonas, W.B., Kaptchuk,T.J. and Linde, K. (2003) A critical overview of homeopathy. 
Annals of Internal Medicine, 138: 393-399.  
 
Jütte, R. and Riley, D. (2005) A review of the use and role of low potencies in 
homeopathy. Complementary Therapies in Medicine, 13(4):291-296. 
 
Karachanak-Yankova, S., Dimova, R., Nikolova, D., Nesheva, D., Koprinarova, M., 
Maslyankov, S., Tafradjiska, R., Gateva, P., Velizarova, M., Hammoudeh, Z., Stoynev, 
N., Toncheva, D., Tankova, T., Dimova, I. (2016) Epigenetic alterations in patients with 
type 2 diabetes mellitus. Balkan Journal of Medical Genetics, 18(2):15–24.  doi: 
10.1515/bjmg-2015-0081 
 
Kaviani, A., Djavid, G.E., Ataie-Fashtami, L., Fateh, M., Ghodsi, M., Salami, M., Zand, N., 
Kashef, N. and Larijani, B. (2011) A randomized clinical trial on the effect of low-level 
laser therapy on chronic diabetic foot wound healing: a preliminary report. Photomedicine 
and Laser Surgery, 29(2):109-114. doi: 10.1089/pho.2009.2680 
 
Kim, L.S., Waters, R.F. and Burkholder, P.M. (2002) Immunological activity of larch 
arabinogalactan and Echinacea: a preliminary, randomized, double-blind, placebo-
controlled trial. Alternative Medicine Review, 7(2):138-149. 
 
Kirby, B.J. (2002) Safety of homeopathic products. Journal of the Royal Society of 
Medicine, 95(5):221-222. 
 
77 
 
Kuhudzai, A. (2019) STATKON Statistical Analysis [Personal communication, 19 
February 2019]. 20 Chiselhurst House, University of Johannesburg, Auckland Park 
Campus, tel: (011) 559 2851. 
 
Lan, C.C., Wu, C.S., Huang, S.M., Wu, I.H. and Chen, G.S. (2013) High-glucose 
environment enhanced oxidative stress and increased interleukin-8 secretion from 
keratinocytes: New insights on impaired diabetic wound healing. Diabetes, 62(7): 2530-
2538. doi: 10.2337/db12-1714 
 
Liang, C.C., Park, A.Y. and Guan, J.L. (2007) In vitro scratch assay: a convenient and 
inexpensive method for analysis of cell migration in vitro. Nature Protocols, 2(2): 329-333. 
doi: 10.1038/nprot.2007.30 
 
Lin, Z.Q., Kondo, T., Ishida, Y., Takayasu, T. and Mukaida, N. (2003) Essential 
involvement of IL‐6 in the skin wound‐healing process as evidenced by delayed wound 
healing in IL‐6‐deficient mice. Journal of Leukocyte Biology, 73(6):713-721. doi: 
10.1189/jlb.0802397 
 
Lima, A.A., Spínola, L.G., Baccan, G., Correia, K., Oliva, M., Vasconcelos, J.F., Soares, 
M.B., Reis, S.R. and Medrado, A.P. (2014) Evaluation of corticosterone and IL-1β, IL-6, 
IL-10 and TNF-α expression after 670-nm laser photobiomodulation in rats. Lasers in 
Medical Science, 29(2):709-715. doi: 10.1007/s10103-013-1356-8 
 
Linde, K. Clausius, N., Ramirez, G., Melchart, D., Eitel, F., Hedges, L.V. and Jonas, W.B. 
(1997) Are the clinical effects of homoeopathy placebo effects? A meta-analysis of 
placebo-controlled trials. Lancet, 350:834-843. doi: 10.1016/S0140-6736(97)02293-9 
 
Loots, M.A., Lamme, E.N., Zeegelaar, J., Mekkes, J.R., Bos, J.D. and Middelkoop, E., 
(1998) Differences in cellular infiltrate and extracellular matrix of chronic diabetic and 
venous ulcers versus acute wounds. Journal of Investigative Dermatology, 111(5):850-
857. doi: 10.1046/j.1523-1747.1998.00381.x 
 
78 
 
Lopes-Martins, R.A., Albertini, R., Lopes, P.S.L., Bjordal, J.M. and Neto, H.C. (2005) 
Spontaneous effects of low-level laser therapy (650 nm) in acute inflammatory mouse 
pleurisy induced by carrageenan. Photomedicine and Laser Therapy, 23(4):377-381. doi: 
10.1089/pho.2005.23.377 
 
Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Tuomi, T., Berglund, G., 
Altshuler, D., Nilsson, P. and Groop, L. (2008) Clinical risk factors, DNA variants, and the 
development of type 2 diabetes. New England Journal of Medicine, 359(21):2220-2232. 
doi: 10.1056/NEJMoa0801869 
 
Maiya, A.G., Kumar, P. and Nayak, S. (2009) Photo-stimulatory effect of low energy 
helium-neon laser irradiation on excisional diabetic wound healing dynamics in Wistar 
rats. Indian Journal of Dermatology, 54(4):323- 329. doi:10.4103/0019-5154.57606 
 
Manayi, A., Vazirian, M. and Saeidnia, S. (2015) Echinacea purpurea: Pharmacology, 
phytochemistry and analysis methods. Pharmacognosy Reviews, 9(17):63. doi: 
10.4103/0973-7847.156353 
 
Maver, T., Maver, U., Stana Kleinschek, K., Smrke, D.M. and Kreft, S. (2015) A review of 
herbal medicines in wound healing. International Journal of Dermatology, 54(7):740-751. 
 
Markuson, M., Hanson, D., Anderson, J., Langemo, D., Hunter, S., Thompson, P., 
Paulson, R. and Rustvang, D. (2009) The relationship between hemoglobin A1c values 
and healing time for lower extremity ulcers in individuals with diabetes. Advances in Skin 
& Wound Care, 22(8):365-372. doi: 10.1097/01.ASW.0000358639.45784.cd 
 
Martin, P. and Nunan, R. (2015) Cellular and molecular mechanisms of repair in acute 
and chronic wound healing. British Journal of Dermatology, 173(2):370-378. doi: 
10.1111/bjd.13954 
 
Mathie R.T. (2003) The research evidence base for homeopathy: a fresh assessment of 
the literature. Homeopathy, 92:84-91. doi: 10.1016/S1475-4916(03)00006-7 
 
79 
 
Mignon, C., Uzunbajakava, N.E., Castellano‐Pellicena, I., Botchkareva, N.V. and Tobin, 
D.J. (2018) Differential response of human dermal fibroblast subpopulations to visible and 
near‐infrared light: Potential of photobiomodulation for addressing cutaneous 
conditions. Lasers in Surgery and Medicine, 50(8):859-882. doi: 10.1002/lsm.22823 
 
Miranda, E.F., Diniz, W.A., Gomes, M.V.N., de Oliveira, M.F.D., de Carvalho, P.D.T.C. 
and Leal-Junior, E.C.P (2019) Acute effects of photobiomodulation therapy (PBMT) 
combining laser diodes, light-emitting diodes, and magnetic field in exercise capacity 
assessed by 6MST in patients with COPD: a crossover, randomized, and triple-blinded 
clinical trial. Lasers in Medical Science, 34(4):711-719. doi: 10.1007/s10103-018-2645-z 
 
Mohammadi, R., Amini, K. and Charehsaz, S. (2012) Homeopathic treatment for 
peripheral nerve regeneration: an experimental study in a rat sciatic nerve transection 
nodel. Homeopathy, 101(03):141-146. doi: 10.1016/j.homp.2012.05.002 
 
Moore, K.L., Dalley, A.F. and Agur, A.M.R. (2010) Clinically Oriented Anatomy. Baltimore: 
Lippincott Williams & Wilkins.   
 
Muley, B.P., Khadabadi, S.S. and Banarase, N.B. (2009) Phytochemical constituents and 
pharmacological activities of Calendula officinalis Linn (Asteraceae): a review. Tropical 
Journal of Pharmaceutical Research, 8(5):455-465. 
 
Nahrstedt, A. and Butterweck, V.  (1997) Biologically active and other chemical 
constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry, 30(S 2):129-
134. doi: 10.1055/s-2007-979533 
 
 
Nunan, R., Harding, K.G. and Martin, P. (2014) Clinical challenges of chronic wounds: 
searching for an optimal animal model to recapitulate their complexity. Disease Models & 
Mechanisms, 7(11):1205-1213. doi: 10.1242/dmm.016782 
 
Oláh, A., Szabó-Papp, J., Soeberdt, M., Knie, U., Dähnhardt-Pfeiffer, S., Abels, C. and 
Bíró, T. (2017) Echinacea purpurea-derived alkylamides exhibit potent anti-inflammatory 
80 
 
effects and alleviate clinical symptoms of atopic eczema. Journal of Dermatological 
Science, 88(1):67-77. doi: 1016/j.jdermsci.2017.05.015 
 
Oxelmark, L., Lindberg, A., Löfberg, R., Sternby, B., Eriksson, A., Almer, S., Befrits, R., 
Fossum, B., Karlén, P., Broström, O. and Tysk, C. (2016) Use of complementary and 
alternative medicine in Swedish patients with inflammatory bowel disease: a controlled 
study. European Journal of Gastroenterology & Hepatology, 28(11):1320-1328. doi: 
10.1097/MEG.0000000000000710 
 
Ozougwu, J.C., Obimba, K.C., Belonwu, C.D. and Unakalamba, C.B. (2013) The 
pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. Journal of 
Physiology and Pathophysiology, 4(4):46-57. doi: 10.5897/JPAP2013.0001 
 
Paneni, F., Beckman, J.A., Creager, M.A. and Cosentino, F. (2013) Diabetes and 
vascular disease: pathophysiology, clinical consequences, and medical therapy: part 
I. European Heart Journal, 34(31):2436-2443. doi: 10.1093/eurheartj/eht149 
 
Parente, L.M.L., Júnior, L., de Souza, R., Tresvenzol, L.M.F., Vinaud, M.C., de Paula, 
J.R. and Paulo, N.M. (2012) Wound healing and anti-inflammatory effect in animal models 
of Calendula officinalis L. growing in Brazil. Evidence-Based Complementary and 
Alternative Medicine, 2012: doi: 10.1155/2012/375671 
 
Pedalino, C.M.V., Perazzo, F.F., Carvalho, J.C.T., Martinho, K.S., de O Massoco, C. and 
Bonamin, L.V. (2004) Effect of Atropa belladonna and Echinacea angustifolia in 
homeopathic dilution on experimental peritonitis. Homeopathy, 93(04):193-198. doi: 
10.1016/j.homp.2004.07.004 
 
Pinheiro, S.L., Bonadiman, A.C., Borges Lemos, A.L.D.A., Annicchino, B.M., Segatti, B., 
Pucca, D.S., Dutra, P.T., de Carvalho e Silva, R.M. and Leal, F. (2019) 
Photobiomodulation Therapy in Cancer Patients with Mucositis: A Clinical 
Evaluation. Photobiomodulation, Photomedicine, and Laser Surgery, 37(3):142-150. doi: 
10.1089/photob.2018.4526 
 
81 
 
Raak, C., Büssing, A., Gassmann, G., Boehm, K. and Ostermann, T. (2012) A systematic 
review and meta-analysis on the use of Hypericum perforatum (St. John's Wort) for pain 
conditions in dental practice. Homeopathy, 101(04):204-210. doi: 
10.1016/j.homp.2012.08.001 
 
Ragnarson Tennvall, G. and Apelqvist, J. (2004) Health-economic consequences of 
diabetic foot lesions. Clinical Infectious Diseases, 39(Supplement_2):S132-S139. doi: 
1058-4838/2004/3903S2-0011 
 
Ramos, R.M., Burland, M., Silva, J.B., Burman, L.M., Gelain, M.S., Debom, L.M., Bec, 
J.M., Alirezai, M., Uebel, C.O. and Valmier, J. (2019) Photobiomodulation improved the 
first stages of wound healing process after abdominoplasty: an experimental, double-
blinded, non-randomized clinical trial. Aesthetic Plastic Surgery, 43(1):147-154. doi: 
10.1007/s00266-018-1271-2 
 
Raskin, P., Pietri, A.O., Unger, R. and Shannon Jr, W.A. (1983) The effect of diabetic 
control on the width of skeletal-muscle capillary basement membrane in patients with type 
I diabetes mellitus. New England Journal of Medicine, 309(25):1546-1550. 
 
Relton, C., Cooper, K., Viksveen, P., Fibert, P. and Thomas, K. (2017) Prevalence of 
homeopathy use by the general population worldwide: a systematic 
review. Homeopathy, 106(02):69-78. doi: 10.1016/j.homp.2017.03.002 
 
Rezaie, A., Najafzadeh, H., Poormahdi-Broojeni, M., Mohammadian, B. and Heidari, M. 
(2013) Effects of Echinacea purpura on wound healing after arsenic induced skin 
necrosis. Zahedan Journal of Research in Medical Sciences, 15(11):19-23. 
 
Rigato, M., Pizzol, D., Tiago, A., Putoto, G., Avogaro, A. and Fadini, G.P. (2018) 
Characteristics, prevalence, and outcomes of diabetic foot ulcers in Africa. A systemic 
review and meta-analysis. Diabetes Research and Clinical Practice, 142:63-73. doi: 
10.1016/j.diabres.2018.05.016 
 
82 
 
Rodriguez L.G., Wu X., Guan J.L. (2005) Wound-Healing Assay. In: Guan J.L. (eds) 
Cell Migration. Methods in Molecular Biology vol 294. Totowa, New Jersey: Humana 
Press. doi: https://doi.org/10.1385/1-59259-860-9:023 
 
Roglic, G. and Unwin, N. (2010) Mortality attributable to diabetes: estimates for the year 
2010. Diabetes Research and Clinical Practice, 8(1):15-19. doi: 
10.1016/j.diabres.2009.10.006 
 
Russo, E., Scicchitano, F., Whalley, B.J., Mazzitello, C., Ciriaco, M., Esposito, S., Patanè, 
M., Upton, R., Pugliese, M., Chimirri, S. and Mammì, M. (2014) Hypericum perforatum: 
pharmacokinetic, mechanism of action, tolerability, and clinical drug–drug 
interactions. Phytotherapy Research, 28(5):643-655. doi:10.1002/ptr.5050 
 
Samadi, S., Khadivzadeh, T., Emami, A., Moosavi, N.S., Tafaghodi, M. and Behnam, 
H.R. (2010) The effect of Hypericum perforatum on the wound healing and scar of 
cesarean. The Journal of Alternative and Complementary Medicine, 16(1):113-117. 
 
Shrivastava, S.R., Shrivastava, P.S. and Ramasamy, J. (2015) Mainstreaming of 
Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy with the health care 
delivery system in India. Journal of Traditional and Complementary Medicine, 5(2):116-
118. doi: 10.1016/j.jtcme.2014.11.002 
 
Singh, M., Nuutila, K., Sinha, I. and Eriksson, E. (2016) Endotoxin‐induced inflammation 
in a rodent model up‐regulates IL‐1a expression and CD45+ leukocyte recruitment and 
increases the rate of reepithelialization and wound closure. Wound Repair and 
Regeneration, 24(5):820-828. doi: 10.1111/wrr.12461 
 
Singh, N., Armstrong, D.G. and Lipsky, B.A. (2005) Preventing foot ulcers in patients with 
diabetes. Journal of the American Medical Association, 293(2):217-228. doi: 
10.1001/jama.293.2.217 
 
Sinha, Y. (1981) Miracles of mother tinctures with therapeutic hints and treatment of 
diseases. New Delhi: B Jain Publishers.  
 
83 
Sohn, M.W., Stuck, R.M., Pinzur, M., Lee, T.A. and Budiman-Mak, E. (2010) Lower-
extremity amputation risk after Charcot arthropathy and diabetic foot ulcer. Diabetes 
Care, 33(1):98-100. doi: 10.2337/dc09-1497 
Sundararaj, K.P., Samuvel, D.J., Li, Y., Sanders, J.J., Lopes-Virella, M.F. and Huang, Y. 
(2009) Interleukin-6 released from fibroblasts is essential for up-regulation of matrix 
metalloproteinase-1 expression by U937 macrophages in coculture cross-talking 
between fibroblasts and U937 macrophages exposed to high glucose. Journal of 
Biological Chemistry, 284(20):13714-13724. doi: 10.1074/jbc.M806573200 
Süntar, I.P., Akkol, E.K., Yılmazer, D., Baykal, T., Kırmızıbekmez, H., Alper, M. and 
Yeşilada, E. (2010) Investigations on the in vivo wound healing potential of Hypericum 
perforatum L. Journal of Ethnopharmacology, 127(2):468-477. doi: 
10.1016/j.jep.2009.10.011 
Tanideh, N., Tavakoli, P., Saghiri, M.A., Garcia-Godoy, F., Amanat, D., Tadbir, A.A., 
Samani, S.M. and Tamadon, A. (2013) Healing acceleration in hamsters of oral mucositis 
induced by 5-fluorouracil with topical Calendula officinalis. Oral Surgery, Oral Medicine, 
Oral Pathology and Oral Radiology, 115(3):332-338. doi: 10.1016/j.oooo.2012.08.450 
Tatmatsu-Rocha, J.C., Tim, C.R., Avo, L., Bernardes-Filho, R., Brassolatti, P., Kido, H.W., 
Hamblin, M.R. and Parizotto, N.A. (2018) Mitochondrial dynamics (fission and fusion) and 
collagen production in a rat model of diabetic wound healing treated by 
photobiomodulation: comparison of 904 nm laser and 850 nm light-emitting diode 
(LED). Journal of Photochemistry and Photobiology B: Biology, 187:41-47. doi: 
10.1016/j.jphotobiol.2018.07.032 
Thangarajah, H., Yao, D., Chang, E.I., Shi, Y., Jazayeri, L., Vial, I.N., Galiano, R.D., Du, 
X.L., Grogan, R., Galvez, M.G. and Januszyk, M. (2009) The molecular basis for impaired
hypoxia-induced VEGF expression in diabetic tissues. Proceedings of the National 
Academy of Sciences, 106(32):13505-13510. doi:  10.1073/pnas.0906670106 
84 
Tracy, L.E., Minasian, R.A. and Caterson, E.J. (2016) Extracellular matrix and dermal 
fibroblast function in the healing wound. Advances in Wound Care, 5(3):119-136. doi: 
10.1089/wound.2014.0561 
Tricarico, P.M., Zupin, L., Ottaviani, G., Pacor, S., Jean‐Louis, F., Boniotto, M. and 
Crovella, S. (2018) Photobiomodulation therapy promotes in vitro wound healing in 
nicastrin KO HaCaT cells. Journal of Biophotonics, 11(12):p.e201800174. doi: 
10.1002/jbio.201800174 
Tsourdi, E., Barthel, A., Rietzsch, H., Reichel, A. and Bornstein, S.R. (2013) Current 
aspects in the pathophysiology and treatment of chronic wounds in diabetes 
mellitus. BioMed Research International, 2013. doi:10.1155/2013/385641. 
Vincent, A.M., Edwards, J.L., McLean, L.L., Hong, Y., Cerri, F., Lopez, I., Quattrini, A. 
and Feldman, E.L. (2010) Mitochondrial biogenesis and fission in axons in cell culture 
and animal models of diabetic neuropathy. Acta Neuropathologica, 120(4):477-489. doi: 
10.1007/s00401-010-0697-7 
Vlietinck, A., Pieters, L. and Apers, S. (2009) Legal requirements for the quality of herbal 
substances and herbal preparations for the manufacturing of herbal medicinal products 
in the European Union. Planta Medica, 75(07):683-688. doi: 10.1055/s-0029-1185307 
Wetzler, C., Kämpfer, H., Stallmeyer, B., Pfeilschifter, J. and Frank, S. (2000) Large and 
sustained induction of chemokines during impaired wound healing in the genetically 
diabetic mouse: prolonged persistence of neutrophils and macrophages during the late 
phase of repair. Journal of Investigative Dermatology, 115(2):245-253. doi: 
10.1046/j.1523-1747.2000.00029.x 
Wode, K., Henriksson, R., Sharp, L., Stoltenberg, A. and Nordberg, J.H. (2019) Cancer 
patients’ use of complementary and alternative medicine in Sweden: a cross-sectional 
study. BMC Complementary and Alternative Medicine, 19(1):62. doi: 10.1186/s12906-
019-2452-5
85 
World Health Organization (WHO) (2020). Traditional, complementary and integrative 
medicine. Available from: https://www.who.int/traditional-complementary-integrative-
medicine/about/en/ [Accessed 12 March 2020] 
Xuan, Y.H., Huang, B.B., Tian, H.S., Chi, L.S., Duan, Y.M., Wang, X., Zhu, Z.X., Cai, 
W.H., Zhu, Y.T., Wei, T.M. and Ye, H.B. (2014) High-glucose inhibits human fibroblast
cell migration in wound healing via repression of bFGF-regulating JNK 
phosphorylation. PloS One, 9(9):p.e108182. doi: 10.1371/journal.pone.0108182 
Yoshimura, T.M., Sabino, C.P. and Ribeiro, M.S. (2016) Photobiomodulation reduces 
abdominal adipose tissue inflammatory infiltrate of diet‐induced obese and hyperglycemic 
mice. Journal of Biophotonics, 9(11-12):1255-1262. doi: 10.1002/jbio.201600088 
Young, B., Lowe, J.S., Stevens, A., Heath, J.W. (2006) Wheater’s functional histology: a 
text and colour atlas. London: Churchill Livingstone. 
86 
APPENDICES 
APPENDIX A 
MANUFACTURING METHOD FOR HOMEOPATHIC REMEDY 
As performed by Fusion Homeopathics CC, South Africa 
All three remedies were manufactured according to the German Homeopathic 
Pharmacopoeia (GHP/HAB) method 3A 
1. Mother tincture* of C. officinalis, H. perforatum and E. purpurea was sourced from
reputable Swiss and German suppliers (quality guaranteed by Certificate of
Analysis). *The mother tincture consists of the fresh plant extract made by mixing
33.3 parts of the plant to 66.7 parts ethanol to give a final ethanol concentration of
60% (m/m)
2. The first centesimal dilution (1 cH) of the three separate remedies - C. officinalis,
H. perforatum and E. purpurea was made by adding 3 parts tincture to 97 parts
ethanol (62%) and succussing the solution (vigorously mixing by striking against a 
firm surface) 100 times 
3. The second centesimal dilution (2 cH) of all three remedies were made using 1
part of the 1 cH solution and adding it to 99 parts ethanol (43%) and succussing
100 times
4. The third centesimal dilution (3 cH) was made in combination, by adding each
remedy in a ratio of 1:100 to the vehicle, and then succussing the mixture together
100 times. The final required solvent (i.e. distilled water, 2.5%, 5% or 10% ethanol)
was used as vehicle in each case.
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APPENDIX E 
LIST OF CONSUMABLES AND CALCULATIONS 
E1 List of Consumables 
PRODUCT PROVIDER CATALOGUE 
NUMBER 
1 mL disposable sterile pipettes BD Biosciences, The Scientific Group 35 7522 
2 mL disposable sterile pipettes Bibby Sterilin Ltd 40102 
5 mL disposable sterile pipettes BD Biosciences, The Scientific Group BD 357543 
10 mL disposable sterile pipettes Corning, The Scientific Group 4101 
75 cm2 sterile culture flasks (T75) Corning, The Scientific Group 431464U 
175 cm2 sterile culture flasks (T175) Corning, The Scientific Group 431466 
96-well clear microplates Greiner Bio-One 655161 
96-well white microplates Greiner Bio-One 655075 
3.4 cm diameter tissue culture plates Corning, The Scientific Group 430165 
Absolute ethanol Sigma-Aldrich 32221 
Amphotericin-B Sigma-Aldrich A2942 
CellTiter-Glo® 3D Cell Viability Assay Promega G9682 
Corning pipette tips (1-200 µL) Corning, The Scientific Group CR 411S 
Corning pipette tips (100-1000 µL) Corning, The Scientific Group CR 4114S 
Cryoprotective vials Corning, The Scientific Group 430489 
CytoTox 96® Non-Radioactive Cytotoxicity 
Assay 
Promega G1782 
Biofreeze Biochrom GmbH F2270 
ELISA kit human TNF-α Elabscience® E-EL-H0109 
ELISA kit human IL-6 Elabscience® E-EL-H0102 
Eppendorf® microtube (500 µL) Sigma-Aldrich Z666521 
Eppendorf® microtube (1.5 mL) Sigma-Aldrich Z666505 
Falcon® centrifuge tube (50 mL) Corning, The Scientific Group 352070 
Foetal bovine serum Gibco®, Life Technologies 10499-044 
(D+) Glucose SaarChem, Muldersdrift, South Africa 267600 
Hanks’ Balanced Salt Solution + Ca2+ and 
Mg2+ 
Sigma-Aldrich H9394 
L-glutamine Sigma-Aldrich G7513  
Minimum Essential Medium Sigma-Aldrich M2279  
Non-essential amino acid Sigma-Aldrich M7145  
Penicillin-streptomycin Sigma-Aldrich P4333 
Sodium pyruvate Sigma-Aldrich S8636  
Trypan Blue Sigma-Aldrich T6146 
TrypLE™ Select (1X) Gibco®, Life Technologies 12563-029 
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E2 Media, Chemicals and Solutions 
 
E2.1 Preparation of complete culture media 
Constituent Volume in 50 mL 
MEM 42 mL 
FBS (10%) 5 mL  
Penicillin-Streptomycin (1%) 0.5 mL 
Amphotericin B (1%) 0.5 mL 
2 mM L-Glutamine 1 mL 
0.1 mM Non-essential amino acids 0.5 mL 
1 mM Sodium pyruvate 0.5 mL 
 
E2.2 Preparation of complete diabetic media 
Constituent Volume in 50 mL 
Complete MEM 49.1 mL 
1 M stock D-glucose  0.9 mL 
 
E2.3 Preparation of stock 1 M D-glucose 
Constituent To make 100 mL 
D-glucose 18 g 
Distilled water (Autoclaved at 121 °C) 100 mL 
*The stock solution was stored at 4 °C 
 
E2.4 Calculation of number of cells for seeding in 3.4 cm diameter tissue  
culture plates  
A concentration of 6 X 105 cells per 3.4 cm plate was required, in a volume of 3 mL culture 
medium. The formula used to calculate the number of plates that can be seeded from n 
viable cells is shown here: 
Number of plates = Total number of viable cells/Total amount of cells required 
Volume to be seeded = Volume required/Number of plates 
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APPENDIX F 
ATCC WS1 DATASHEET  
 
